Unacceptable principal diagnosis - ICD-10 Code Edits

The following 2,373 ICD-10 codes are intended for unacceptable principal diagnosis


ICD CodeDescriptionCategory
B60.13Keratoconjunctivitis due to AcanthamoebaOther protozoal diseases, not elsewhere classified (B60)
B95.0Streptococcus, group A, as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.1Streptococcus, group B, as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.2Enterococcus as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.3Streptococcus pneumoniae as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.4Other streptococcus as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.5Unspecified streptococcus as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.61Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.62Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.7Other staphylococcus as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B95.8Unspecified staphylococcus as the cause of diseases classified elsewhereStrep as the cause of diseases classified elsewhere (B95)
B96.0Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.1Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.20Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.21Shiga toxin-producing Escherichia coli [E. coli] (STEC) O157 as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.22Other specified Shiga toxin-producing Escherichia coli [E. coli] (STEC) as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.23Unspecified Shiga toxin-producing Escherichia coli [E. coli] (STEC) as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.29Other Escherichia coli [E. coli] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.3Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.4Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.5Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.6Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.7Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.81Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.82Vibrio vulnificus as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B96.89Other specified bacterial agents as the cause of diseases classified elsewhereOth bacterial agents as the cause of diseases classd elswhr (B96)
B97.0Adenovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.10Unspecified enterovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.11Coxsackievirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.12Echovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.19Other enterovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.21SARS-associated coronavirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.29Other coronavirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.30Unspecified retrovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.31Lentivirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.32Oncovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.33Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.34Human T-cell lymphotrophic virus, type II [HTLV-II] as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.35Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.39Other retrovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.4Respiratory syncytial virus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.5Reovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.6Parvovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.7Papillomavirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.81Human metapneumovirus as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
B97.89Other viral agents as the cause of diseases classified elsewhereViral agents as the cause of diseases classified elsewhere (B97)
C80.2Malignant neoplasm associated with transplanted organMalignant neoplasm without specification of site (C80)
D47.Z1Post-transplant lymphoproliferative disorder (PTLD)Oth neoplm of uncrt behav of lymphoid, hematpoetc & rel tiss (D47)
D89.810Acute graft-versus-host diseaseOth disorders involving the immune mechanism, NEC (D89)
D89.811Chronic graft-versus-host diseaseOth disorders involving the immune mechanism, NEC (D89)
D89.812Acute on chronic graft-versus-host diseaseOth disorders involving the immune mechanism, NEC (D89)
D89.813Graft-versus-host disease, unspecifiedOth disorders involving the immune mechanism, NEC (D89)
F07.89Other personality and behavioral disorders due to known physiological conditionPersonality & behavrl disorders due to known physiol cond (F07)
F17.200Nicotine dependence, unspecified, uncomplicatedNicotine dependence (F17)
F17.201Nicotine dependence, unspecified, in remissionNicotine dependence (F17)
F17.210Nicotine dependence, cigarettes, uncomplicatedNicotine dependence (F17)
F17.211Nicotine dependence, cigarettes, in remissionNicotine dependence (F17)
F17.220Nicotine dependence, chewing tobacco, uncomplicatedNicotine dependence (F17)
F17.221Nicotine dependence, chewing tobacco, in remissionNicotine dependence (F17)
F17.290Nicotine dependence, other tobacco product, uncomplicatedNicotine dependence (F17)
F17.291Nicotine dependence, other tobacco product, in remissionNicotine dependence (F17)
F52.9Unspecified sexual dysfunction not due to a substance or known physiological conditionSexual dysfnct not due to a substance or known physiol cond (F52)
F81.9Developmental disorder of scholastic skills, unspecifiedSpecific developmental disorders of scholastic skills (F81)
G54.3Thoracic root disorders, not elsewhere classifiedNerve root and plexus disorders (G54)
G73.1Lambert-Eaton syndrome in neoplastic diseaseDisord of myoneural junction and muscle in dis classd elswhr (G73)
H16.8Other keratitisKeratitis (H16)
H40.1210Low-tension glaucoma, right eye, stage unspecifiedGlaucoma (H40)
H40.1211Low-tension glaucoma, right eye, mild stageGlaucoma (H40)
H40.1212Low-tension glaucoma, right eye, moderate stageGlaucoma (H40)
H40.1213Low-tension glaucoma, right eye, severe stageGlaucoma (H40)
H40.1214Low-tension glaucoma, right eye, indeterminate stageGlaucoma (H40)
H40.1220Low-tension glaucoma, left eye, stage unspecifiedGlaucoma (H40)
H40.1221Low-tension glaucoma, left eye, mild stageGlaucoma (H40)
H40.1222Low-tension glaucoma, left eye, moderate stageGlaucoma (H40)
H40.1223Low-tension glaucoma, left eye, severe stageGlaucoma (H40)
H40.1224Low-tension glaucoma, left eye, indeterminate stageGlaucoma (H40)
H40.1230Low-tension glaucoma, bilateral, stage unspecifiedGlaucoma (H40)
H40.1231Low-tension glaucoma, bilateral, mild stageGlaucoma (H40)
H40.1232Low-tension glaucoma, bilateral, moderate stageGlaucoma (H40)
H40.1233Low-tension glaucoma, bilateral, severe stageGlaucoma (H40)
H40.1234Low-tension glaucoma, bilateral, indeterminate stageGlaucoma (H40)
H40.1290Low-tension glaucoma, unspecified eye, stage unspecifiedGlaucoma (H40)
H40.1291Low-tension glaucoma, unspecified eye, mild stageGlaucoma (H40)
H40.1292Low-tension glaucoma, unspecified eye, moderate stageGlaucoma (H40)
H40.1293Low-tension glaucoma, unspecified eye, severe stageGlaucoma (H40)
H40.1294Low-tension glaucoma, unspecified eye, indeterminate stageGlaucoma (H40)
H40.1310Pigmentary glaucoma, right eye, stage unspecifiedGlaucoma (H40)
H40.1311Pigmentary glaucoma, right eye, mild stageGlaucoma (H40)
H40.1312Pigmentary glaucoma, right eye, moderate stageGlaucoma (H40)
H40.1313Pigmentary glaucoma, right eye, severe stageGlaucoma (H40)
H40.1314Pigmentary glaucoma, right eye, indeterminate stageGlaucoma (H40)
H40.1320Pigmentary glaucoma, left eye, stage unspecifiedGlaucoma (H40)
H40.1321Pigmentary glaucoma, left eye, mild stageGlaucoma (H40)
H40.1322Pigmentary glaucoma, left eye, moderate stageGlaucoma (H40)
H40.1323Pigmentary glaucoma, left eye, severe stageGlaucoma (H40)
H40.1324Pigmentary glaucoma, left eye, indeterminate stageGlaucoma (H40)
H40.1330Pigmentary glaucoma, bilateral, stage unspecifiedGlaucoma (H40)
H40.1331Pigmentary glaucoma, bilateral, mild stageGlaucoma (H40)
H40.1332Pigmentary glaucoma, bilateral, moderate stageGlaucoma (H40)
H40.1333Pigmentary glaucoma, bilateral, severe stageGlaucoma (H40)
H40.1334Pigmentary glaucoma, bilateral, indeterminate stageGlaucoma (H40)
H40.1390Pigmentary glaucoma, unspecified eye, stage unspecifiedGlaucoma (H40)
H40.1391Pigmentary glaucoma, unspecified eye, mild stageGlaucoma (H40)
H40.1392Pigmentary glaucoma, unspecified eye, moderate stageGlaucoma (H40)
H40.1393Pigmentary glaucoma, unspecified eye, severe stageGlaucoma (H40)
H40.1394Pigmentary glaucoma, unspecified eye, indeterminate stageGlaucoma (H40)
H40.151Residual stage of open-angle glaucoma, right eyeGlaucoma (H40)
H40.152Residual stage of open-angle glaucoma, left eyeGlaucoma (H40)
H40.153Residual stage of open-angle glaucoma, bilateralGlaucoma (H40)
H40.159Residual stage of open-angle glaucoma, unspecified eyeGlaucoma (H40)
H54.7Unspecified visual lossBlindness and low vision (H54)
H57.9Unspecified disorder of eye and adnexaOther disorders of eye and adnexa (H57)
H93.90Unspecified disorder of ear, unspecified earOther disorders of ear, not elsewhere classified (H93)
H93.91Unspecified disorder of right earOther disorders of ear, not elsewhere classified (H93)
H93.92Unspecified disorder of left earOther disorders of ear, not elsewhere classified (H93)
H93.93Unspecified disorder of ear, bilateralOther disorders of ear, not elsewhere classified (H93)
I25.82Chronic total occlusion of coronary arteryChronic ischemic heart disease (I25)
I25.83Coronary atherosclerosis due to lipid rich plaqueChronic ischemic heart disease (I25)
I25.84Coronary atherosclerosis due to calcified coronary lesionChronic ischemic heart disease (I25)
I26.01Septic pulmonary embolism with acute cor pulmonalePulmonary embolism (I26)
I26.90Septic pulmonary embolism without acute cor pulmonalePulmonary embolism (I26)
I31.4Cardiac tamponadeOther diseases of pericardium (I31)
I70.92Chronic total occlusion of artery of the extremitiesAtherosclerosis (I70)
I76Septic arterial embolismSeptic arterial embolism (I76)
J93.12Secondary spontaneous pneumothoraxPneumothorax and air leak (J93)
K76.81Hepatopulmonary syndromeOther diseases of liver (K76)
L49.0Exfoliation due to erythematous condition involving less than 10 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.1Exfoliation due to erythematous condition involving 10-19 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.2Exfoliation due to erythematous condition involving 20-29 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.3Exfoliation due to erythematous condition involving 30-39 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.4Exfoliation due to erythematous condition involving 40-49 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.5Exfoliation due to erythematous condition involving 50-59 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.6Exfoliation due to erythematous condition involving 60-69 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.7Exfoliation due to erythematous condition involving 70-79 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.8Exfoliation due to erythematous condition involving 80-89 percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
L49.9Exfoliation due to erythematous condition involving 90 or more percent of body surfaceExfoliatn due to erythemat cond accord extent body involv (L49)
N64.1Fat necrosis of breastOther disorders of breast (N64)
O09.00Supervision of pregnancy with history of infertility, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.01Supervision of pregnancy with history of infertility, first trimesterSupervision of high risk pregnancy (O09)
O09.02Supervision of pregnancy with history of infertility, second trimesterSupervision of high risk pregnancy (O09)
O09.03Supervision of pregnancy with history of infertility, third trimesterSupervision of high risk pregnancy (O09)
O09.10Supervision of pregnancy with history of ectopic pregnancy, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.11Supervision of pregnancy with history of ectopic pregnancy, first trimesterSupervision of high risk pregnancy (O09)
O09.12Supervision of pregnancy with history of ectopic pregnancy, second trimesterSupervision of high risk pregnancy (O09)
O09.13Supervision of pregnancy with history of ectopic pregnancy, third trimesterSupervision of high risk pregnancy (O09)
O09.211Supervision of pregnancy with history of pre-term labor, first trimesterSupervision of high risk pregnancy (O09)
O09.212Supervision of pregnancy with history of pre-term labor, second trimesterSupervision of high risk pregnancy (O09)
O09.213Supervision of pregnancy with history of pre-term labor, third trimesterSupervision of high risk pregnancy (O09)
O09.219Supervision of pregnancy with history of pre-term labor, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.291Supervision of pregnancy with other poor reproductive or obstetric history, first trimesterSupervision of high risk pregnancy (O09)
O09.292Supervision of pregnancy with other poor reproductive or obstetric history, second trimesterSupervision of high risk pregnancy (O09)
O09.293Supervision of pregnancy with other poor reproductive or obstetric history, third trimesterSupervision of high risk pregnancy (O09)
O09.299Supervision of pregnancy with other poor reproductive or obstetric history, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.30Supervision of pregnancy with insufficient antenatal care, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.31Supervision of pregnancy with insufficient antenatal care, first trimesterSupervision of high risk pregnancy (O09)
O09.32Supervision of pregnancy with insufficient antenatal care, second trimesterSupervision of high risk pregnancy (O09)
O09.33Supervision of pregnancy with insufficient antenatal care, third trimesterSupervision of high risk pregnancy (O09)
O09.40Supervision of pregnancy with grand multiparity, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.41Supervision of pregnancy with grand multiparity, first trimesterSupervision of high risk pregnancy (O09)
O09.42Supervision of pregnancy with grand multiparity, second trimesterSupervision of high risk pregnancy (O09)
O09.43Supervision of pregnancy with grand multiparity, third trimesterSupervision of high risk pregnancy (O09)
O09.511Supervision of elderly primigravida, first trimesterSupervision of high risk pregnancy (O09)
O09.512Supervision of elderly primigravida, second trimesterSupervision of high risk pregnancy (O09)
O09.513Supervision of elderly primigravida, third trimesterSupervision of high risk pregnancy (O09)
O09.519Supervision of elderly primigravida, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.521Supervision of elderly multigravida, first trimesterSupervision of high risk pregnancy (O09)
O09.522Supervision of elderly multigravida, second trimesterSupervision of high risk pregnancy (O09)
O09.523Supervision of elderly multigravida, third trimesterSupervision of high risk pregnancy (O09)
O09.529Supervision of elderly multigravida, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.611Supervision of young primigravida, first trimesterSupervision of high risk pregnancy (O09)
O09.612Supervision of young primigravida, second trimesterSupervision of high risk pregnancy (O09)
O09.613Supervision of young primigravida, third trimesterSupervision of high risk pregnancy (O09)
O09.619Supervision of young primigravida, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.621Supervision of young multigravida, first trimesterSupervision of high risk pregnancy (O09)
O09.622Supervision of young multigravida, second trimesterSupervision of high risk pregnancy (O09)
O09.623Supervision of young multigravida, third trimesterSupervision of high risk pregnancy (O09)
O09.629Supervision of young multigravida, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.70Supervision of high risk pregnancy due to social problems, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.71Supervision of high risk pregnancy due to social problems, first trimesterSupervision of high risk pregnancy (O09)
O09.72Supervision of high risk pregnancy due to social problems, second trimesterSupervision of high risk pregnancy (O09)
O09.73Supervision of high risk pregnancy due to social problems, third trimesterSupervision of high risk pregnancy (O09)
O09.811Supervision of pregnancy resulting from assisted reproductive technology, first trimesterSupervision of high risk pregnancy (O09)
O09.812Supervision of pregnancy resulting from assisted reproductive technology, second trimesterSupervision of high risk pregnancy (O09)
O09.813Supervision of pregnancy resulting from assisted reproductive technology, third trimesterSupervision of high risk pregnancy (O09)
O09.819Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.821Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimesterSupervision of high risk pregnancy (O09)
O09.822Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimesterSupervision of high risk pregnancy (O09)
O09.823Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimesterSupervision of high risk pregnancy (O09)
O09.829Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.891Supervision of other high risk pregnancies, first trimesterSupervision of high risk pregnancy (O09)
O09.892Supervision of other high risk pregnancies, second trimesterSupervision of high risk pregnancy (O09)
O09.893Supervision of other high risk pregnancies, third trimesterSupervision of high risk pregnancy (O09)
O09.899Supervision of other high risk pregnancies, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.90Supervision of high risk pregnancy, unspecified, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.91Supervision of high risk pregnancy, unspecified, first trimesterSupervision of high risk pregnancy (O09)
O09.92Supervision of high risk pregnancy, unspecified, second trimesterSupervision of high risk pregnancy (O09)
O09.93Supervision of high risk pregnancy, unspecified, third trimesterSupervision of high risk pregnancy (O09)
O09.A0Supervision of pregnancy with history of molar pregnancy, unspecified trimesterSupervision of high risk pregnancy (O09)
O09.A1Supervision of pregnancy with history of molar pregnancy, first trimesterSupervision of high risk pregnancy (O09)
O09.A2Supervision of pregnancy with history of molar pregnancy, second trimesterSupervision of high risk pregnancy (O09)
O09.A3Supervision of pregnancy with history of molar pregnancy, third trimesterSupervision of high risk pregnancy (O09)
O36.80X0Pregnancy with inconclusive fetal viability, not applicable or unspecifiedMaternal care for other fetal problems (O36)
O36.80X1Pregnancy with inconclusive fetal viability, fetus 1Maternal care for other fetal problems (O36)
O36.80X2Pregnancy with inconclusive fetal viability, fetus 2Maternal care for other fetal problems (O36)
O36.80X3Pregnancy with inconclusive fetal viability, fetus 3Maternal care for other fetal problems (O36)
O36.80X4Pregnancy with inconclusive fetal viability, fetus 4Maternal care for other fetal problems (O36)
O36.80X5Pregnancy with inconclusive fetal viability, fetus 5Maternal care for other fetal problems (O36)
O36.80X9Pregnancy with inconclusive fetal viability, other fetusMaternal care for other fetal problems (O36)
O94Sequelae of complication of pregnancy, childbirth, and the puerperiumSequelae of comp of pregnancy, chldbrth, and the puerperium (O94)
O99.820Streptococcus B carrier state complicating pregnancyOth maternal diseases classd elsw but compl preg/chldbrth (O99)
O99.825Streptococcus B carrier state complicating the puerperiumOth maternal diseases classd elsw but compl preg/chldbrth (O99)
R18.0Malignant ascitesAscites (R18)
R29.700NIHSS score 0Oth symptoms and signs involving the nervous and ms systems (R29)
R29.701NIHSS score 1Oth symptoms and signs involving the nervous and ms systems (R29)
R29.702NIHSS score 2Oth symptoms and signs involving the nervous and ms systems (R29)
R29.703NIHSS score 3Oth symptoms and signs involving the nervous and ms systems (R29)
R29.704NIHSS score 4Oth symptoms and signs involving the nervous and ms systems (R29)
R29.705NIHSS score 5Oth symptoms and signs involving the nervous and ms systems (R29)
R29.706NIHSS score 6Oth symptoms and signs involving the nervous and ms systems (R29)
R29.707NIHSS score 7Oth symptoms and signs involving the nervous and ms systems (R29)
R29.708NIHSS score 8Oth symptoms and signs involving the nervous and ms systems (R29)
R29.709NIHSS score 9Oth symptoms and signs involving the nervous and ms systems (R29)
R29.710NIHSS score 10Oth symptoms and signs involving the nervous and ms systems (R29)
R29.711NIHSS score 11Oth symptoms and signs involving the nervous and ms systems (R29)
R29.712NIHSS score 12Oth symptoms and signs involving the nervous and ms systems (R29)
R29.713NIHSS score 13Oth symptoms and signs involving the nervous and ms systems (R29)
R29.714NIHSS score 14Oth symptoms and signs involving the nervous and ms systems (R29)
R29.715NIHSS score 15Oth symptoms and signs involving the nervous and ms systems (R29)
R29.716NIHSS score 16Oth symptoms and signs involving the nervous and ms systems (R29)
R29.717NIHSS score 17Oth symptoms and signs involving the nervous and ms systems (R29)
R29.718NIHSS score 18Oth symptoms and signs involving the nervous and ms systems (R29)
R29.719NIHSS score 19Oth symptoms and signs involving the nervous and ms systems (R29)
R29.720NIHSS score 20Oth symptoms and signs involving the nervous and ms systems (R29)
R29.721NIHSS score 21Oth symptoms and signs involving the nervous and ms systems (R29)
R29.722NIHSS score 22Oth symptoms and signs involving the nervous and ms systems (R29)
R29.723NIHSS score 23Oth symptoms and signs involving the nervous and ms systems (R29)
R29.724NIHSS score 24Oth symptoms and signs involving the nervous and ms systems (R29)
R29.725NIHSS score 25Oth symptoms and signs involving the nervous and ms systems (R29)
R29.726NIHSS score 26Oth symptoms and signs involving the nervous and ms systems (R29)
R29.727NIHSS score 27Oth symptoms and signs involving the nervous and ms systems (R29)
R29.728NIHSS score 28Oth symptoms and signs involving the nervous and ms systems (R29)
R29.729NIHSS score 29Oth symptoms and signs involving the nervous and ms systems (R29)
R29.730NIHSS score 30Oth symptoms and signs involving the nervous and ms systems (R29)
R29.731NIHSS score 31Oth symptoms and signs involving the nervous and ms systems (R29)
R29.732NIHSS score 32Oth symptoms and signs involving the nervous and ms systems (R29)
R29.733NIHSS score 33Oth symptoms and signs involving the nervous and ms systems (R29)
R29.734NIHSS score 34Oth symptoms and signs involving the nervous and ms systems (R29)
R29.735NIHSS score 35Oth symptoms and signs involving the nervous and ms systems (R29)
R29.736NIHSS score 36Oth symptoms and signs involving the nervous and ms systems (R29)
R29.737NIHSS score 37Oth symptoms and signs involving the nervous and ms systems (R29)
R29.738NIHSS score 38Oth symptoms and signs involving the nervous and ms systems (R29)
R29.739NIHSS score 39Oth symptoms and signs involving the nervous and ms systems (R29)
R29.740NIHSS score 40Oth symptoms and signs involving the nervous and ms systems (R29)
R29.741NIHSS score 41Oth symptoms and signs involving the nervous and ms systems (R29)
R29.742NIHSS score 42Oth symptoms and signs involving the nervous and ms systems (R29)
R40.2110Coma scale, eyes open, never, unspecified timeSomnolence, stupor and coma (R40)
R40.2111Coma scale, eyes open, never, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2112Coma scale, eyes open, never, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2113Coma scale, eyes open, never, at hospital admissionSomnolence, stupor and coma (R40)
R40.2114Coma scale, eyes open, never, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2120Coma scale, eyes open, to pain, unspecified timeSomnolence, stupor and coma (R40)
R40.2121Coma scale, eyes open, to pain, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2122Coma scale, eyes open, to pain, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2123Coma scale, eyes open, to pain, at hospital admissionSomnolence, stupor and coma (R40)
R40.2124Coma scale, eyes open, to pain, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2130Coma scale, eyes open, to sound, unspecified timeSomnolence, stupor and coma (R40)
R40.2131Coma scale, eyes open, to sound, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2132Coma scale, eyes open, to sound, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2133Coma scale, eyes open, to sound, at hospital admissionSomnolence, stupor and coma (R40)
R40.2134Coma scale, eyes open, to sound, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2140Coma scale, eyes open, spontaneous, unspecified timeSomnolence, stupor and coma (R40)
R40.2141Coma scale, eyes open, spontaneous, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2142Coma scale, eyes open, spontaneous, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2143Coma scale, eyes open, spontaneous, at hospital admissionSomnolence, stupor and coma (R40)
R40.2144Coma scale, eyes open, spontaneous, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2210Coma scale, best verbal response, none, unspecified timeSomnolence, stupor and coma (R40)
R40.2211Coma scale, best verbal response, none, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2212Coma scale, best verbal response, none, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2213Coma scale, best verbal response, none, at hospital admissionSomnolence, stupor and coma (R40)
R40.2214Coma scale, best verbal response, none, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2220Coma scale, best verbal response, incomprehensible words, unspecified timeSomnolence, stupor and coma (R40)
R40.2221Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2222Coma scale, best verbal response, incomprehensible words, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2223Coma scale, best verbal response, incomprehensible words, at hospital admissionSomnolence, stupor and coma (R40)
R40.2224Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2230Coma scale, best verbal response, inappropriate words, unspecified timeSomnolence, stupor and coma (R40)
R40.2231Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2232Coma scale, best verbal response, inappropriate words, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2233Coma scale, best verbal response, inappropriate words, at hospital admissionSomnolence, stupor and coma (R40)
R40.2234Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2240Coma scale, best verbal response, confused conversation, unspecified timeSomnolence, stupor and coma (R40)
R40.2241Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2242Coma scale, best verbal response, confused conversation, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2243Coma scale, best verbal response, confused conversation, at hospital admissionSomnolence, stupor and coma (R40)
R40.2244Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2250Coma scale, best verbal response, oriented, unspecified timeSomnolence, stupor and coma (R40)
R40.2251Coma scale, best verbal response, oriented, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2252Coma scale, best verbal response, oriented, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2253Coma scale, best verbal response, oriented, at hospital admissionSomnolence, stupor and coma (R40)
R40.2254Coma scale, best verbal response, oriented, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2310Coma scale, best motor response, none, unspecified timeSomnolence, stupor and coma (R40)
R40.2311Coma scale, best motor response, none, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2312Coma scale, best motor response, none, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2313Coma scale, best motor response, none, at hospital admissionSomnolence, stupor and coma (R40)
R40.2314Coma scale, best motor response, none, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2320Coma scale, best motor response, extension, unspecified timeSomnolence, stupor and coma (R40)
R40.2321Coma scale, best motor response, extension, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2322Coma scale, best motor response, extension, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2323Coma scale, best motor response, extension, at hospital admissionSomnolence, stupor and coma (R40)
R40.2324Coma scale, best motor response, extension, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2330Coma scale, best motor response, abnormal, unspecified timeSomnolence, stupor and coma (R40)
R40.2331Coma scale, best motor response, abnormal, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2332Coma scale, best motor response, abnormal, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2333Coma scale, best motor response, abnormal, at hospital admissionSomnolence, stupor and coma (R40)
R40.2334Coma scale, best motor response, abnormal, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2340Coma scale, best motor response, flexion withdrawal, unspecified timeSomnolence, stupor and coma (R40)
R40.2341Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2342Coma scale, best motor response, flexion withdrawal, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2343Coma scale, best motor response, flexion withdrawal, at hospital admissionSomnolence, stupor and coma (R40)
R40.2344Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2350Coma scale, best motor response, localizes pain, unspecified timeSomnolence, stupor and coma (R40)
R40.2351Coma scale, best motor response, localizes pain, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2352Coma scale, best motor response, localizes pain, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2353Coma scale, best motor response, localizes pain, at hospital admissionSomnolence, stupor and coma (R40)
R40.2354Coma scale, best motor response, localizes pain, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2360Coma scale, best motor response, obeys commands, unspecified timeSomnolence, stupor and coma (R40)
R40.2361Coma scale, best motor response, obeys commands, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2362Coma scale, best motor response, obeys commands, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2363Coma scale, best motor response, obeys commands, at hospital admissionSomnolence, stupor and coma (R40)
R40.2364Coma scale, best motor response, obeys commands, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2410Glasgow coma scale score 13-15, unspecified timeSomnolence, stupor and coma (R40)
R40.2411Glasgow coma scale score 13-15, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2412Glasgow coma scale score 13-15, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2413Glasgow coma scale score 13-15, at hospital admissionSomnolence, stupor and coma (R40)
R40.2414Glasgow coma scale score 13-15, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2420Glasgow coma scale score 9-12, unspecified timeSomnolence, stupor and coma (R40)
R40.2421Glasgow coma scale score 9-12, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2422Glasgow coma scale score 9-12, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2423Glasgow coma scale score 9-12, at hospital admissionSomnolence, stupor and coma (R40)
R40.2424Glasgow coma scale score 9-12, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2430Glasgow coma scale score 3-8, unspecified timeSomnolence, stupor and coma (R40)
R40.2431Glasgow coma scale score 3-8, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2432Glasgow coma scale score 3-8, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2433Glasgow coma scale score 3-8, at hospital admissionSomnolence, stupor and coma (R40)
R40.2434Glasgow coma scale score 3-8, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R40.2440Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified timeSomnolence, stupor and coma (R40)
R40.2441Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]Somnolence, stupor and coma (R40)
R40.2442Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency departmentSomnolence, stupor and coma (R40)
R40.2443Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admissionSomnolence, stupor and coma (R40)
R40.2444Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admissionSomnolence, stupor and coma (R40)
R41.83Borderline intellectual functioningOth symptoms and signs w cognitive functions and awareness (R41)
R45.850Homicidal ideationsSymptoms and signs involving emotional state (R45)
R46.81Obsessive-compulsive behaviorSymptoms and signs involving appearance and behavior (R46)
R46.89Other symptoms and signs involving appearance and behaviorSymptoms and signs involving appearance and behavior (R46)
R65.10Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunctionSymp and signs specifically assoc w sys inflam and infct (R65)
R65.11Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunctionSymp and signs specifically assoc w sys inflam and infct (R65)
R65.20Severe sepsis without septic shockSymp and signs specifically assoc w sys inflam and infct (R65)
R65.21Severe sepsis with septic shockSymp and signs specifically assoc w sys inflam and infct (R65)
T36.0X5AAdverse effect of penicillins, initial encounterSystemic antibiotics (T36)
T36.0X5DAdverse effect of penicillins, subsequent encounterSystemic antibiotics (T36)
T36.0X5SAdverse effect of penicillins, sequelaSystemic antibiotics (T36)
T36.0X6AUnderdosing of penicillins, initial encounterSystemic antibiotics (T36)
T36.0X6DUnderdosing of penicillins, subsequent encounterSystemic antibiotics (T36)
T36.0X6SUnderdosing of penicillins, sequelaSystemic antibiotics (T36)
T36.1X5AAdverse effect of cephalosporins and other beta-lactam antibiotics, initial encounterSystemic antibiotics (T36)
T36.1X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounterSystemic antibiotics (T36)
T36.1X5SAdverse effect of cephalosporins and other beta-lactam antibiotics, sequelaSystemic antibiotics (T36)
T36.1X6AUnderdosing of cephalosporins and other beta-lactam antibiotics, initial encounterSystemic antibiotics (T36)
T36.1X6DUnderdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounterSystemic antibiotics (T36)
T36.1X6SUnderdosing of cephalosporins and other beta-lactam antibiotics, sequelaSystemic antibiotics (T36)
T36.2X5AAdverse effect of chloramphenicol group, initial encounterSystemic antibiotics (T36)
T36.2X5DAdverse effect of chloramphenicol group, subsequent encounterSystemic antibiotics (T36)
T36.2X5SAdverse effect of chloramphenicol group, sequelaSystemic antibiotics (T36)
T36.2X6AUnderdosing of chloramphenicol group, initial encounterSystemic antibiotics (T36)
T36.2X6DUnderdosing of chloramphenicol group, subsequent encounterSystemic antibiotics (T36)
T36.2X6SUnderdosing of chloramphenicol group, sequelaSystemic antibiotics (T36)
T36.3X5AAdverse effect of macrolides, initial encounterSystemic antibiotics (T36)
T36.3X5DAdverse effect of macrolides, subsequent encounterSystemic antibiotics (T36)
T36.3X5SAdverse effect of macrolides, sequelaSystemic antibiotics (T36)
T36.3X6AUnderdosing of macrolides, initial encounterSystemic antibiotics (T36)
T36.3X6DUnderdosing of macrolides, subsequent encounterSystemic antibiotics (T36)
T36.3X6SUnderdosing of macrolides, sequelaSystemic antibiotics (T36)
T36.4X5AAdverse effect of tetracyclines, initial encounterSystemic antibiotics (T36)
T36.4X5DAdverse effect of tetracyclines, subsequent encounterSystemic antibiotics (T36)
T36.4X5SAdverse effect of tetracyclines, sequelaSystemic antibiotics (T36)
T36.4X6AUnderdosing of tetracyclines, initial encounterSystemic antibiotics (T36)
T36.4X6DUnderdosing of tetracyclines, subsequent encounterSystemic antibiotics (T36)
T36.4X6SUnderdosing of tetracyclines, sequelaSystemic antibiotics (T36)
T36.5X5AAdverse effect of aminoglycosides, initial encounterSystemic antibiotics (T36)
T36.5X5DAdverse effect of aminoglycosides, subsequent encounterSystemic antibiotics (T36)
T36.5X5SAdverse effect of aminoglycosides, sequelaSystemic antibiotics (T36)
T36.5X6AUnderdosing of aminoglycosides, initial encounterSystemic antibiotics (T36)
T36.5X6DUnderdosing of aminoglycosides, subsequent encounterSystemic antibiotics (T36)
T36.5X6SUnderdosing of aminoglycosides, sequelaSystemic antibiotics (T36)
T36.6X5AAdverse effect of rifampicins, initial encounterSystemic antibiotics (T36)
T36.6X5DAdverse effect of rifampicins, subsequent encounterSystemic antibiotics (T36)
T36.6X5SAdverse effect of rifampicins, sequelaSystemic antibiotics (T36)
T36.6X6AUnderdosing of rifampicins, initial encounterSystemic antibiotics (T36)
T36.6X6DUnderdosing of rifampicins, subsequent encounterSystemic antibiotics (T36)
T36.6X6SUnderdosing of rifampicins, sequelaSystemic antibiotics (T36)
T36.7X5AAdverse effect of antifungal antibiotics, systemically used, initial encounterSystemic antibiotics (T36)
T36.7X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounterSystemic antibiotics (T36)
T36.7X5SAdverse effect of antifungal antibiotics, systemically used, sequelaSystemic antibiotics (T36)
T36.7X6AUnderdosing of antifungal antibiotics, systemically used, initial encounterSystemic antibiotics (T36)
T36.7X6DUnderdosing of antifungal antibiotics, systemically used, subsequent encounterSystemic antibiotics (T36)
T36.7X6SUnderdosing of antifungal antibiotics, systemically used, sequelaSystemic antibiotics (T36)
T36.8X5AAdverse effect of other systemic antibiotics, initial encounterSystemic antibiotics (T36)
T36.8X5DAdverse effect of other systemic antibiotics, subsequent encounterSystemic antibiotics (T36)
T36.8X5SAdverse effect of other systemic antibiotics, sequelaSystemic antibiotics (T36)
T36.8X6AUnderdosing of other systemic antibiotics, initial encounterSystemic antibiotics (T36)
T36.8X6DUnderdosing of other systemic antibiotics, subsequent encounterSystemic antibiotics (T36)
T36.8X6SUnderdosing of other systemic antibiotics, sequelaSystemic antibiotics (T36)
T36.95XAAdverse effect of unspecified systemic antibiotic, initial encounterSystemic antibiotics (T36)
T36.95XDAdverse effect of unspecified systemic antibiotic, subsequent encounterSystemic antibiotics (T36)
T36.95XSAdverse effect of unspecified systemic antibiotic, sequelaSystemic antibiotics (T36)
T36.96XAUnderdosing of unspecified systemic antibiotic, initial encounterSystemic antibiotics (T36)
T36.96XDUnderdosing of unspecified systemic antibiotic, subsequent encounterSystemic antibiotics (T36)
T36.96XSUnderdosing of unspecified systemic antibiotic, sequelaSystemic antibiotics (T36)
T37.0X5AAdverse effect of sulfonamides, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.0X5DAdverse effect of sulfonamides, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.0X5SAdverse effect of sulfonamides, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.0X6AUnderdosing of sulfonamides, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.0X6DUnderdosing of sulfonamides, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.0X6SUnderdosing of sulfonamides, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.1X5AAdverse effect of antimycobacterial drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.1X5DAdverse effect of antimycobacterial drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.1X5SAdverse effect of antimycobacterial drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.1X6AUnderdosing of antimycobacterial drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.1X6DUnderdosing of antimycobacterial drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.1X6SUnderdosing of antimycobacterial drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.2X5AAdverse effect of antimalarials and drugs acting on other blood protozoa, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.2X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.2X5SAdverse effect of antimalarials and drugs acting on other blood protozoa, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.2X6AUnderdosing of antimalarials and drugs acting on other blood protozoa, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.2X6DUnderdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.2X6SUnderdosing of antimalarials and drugs acting on other blood protozoa, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.3X5AAdverse effect of other antiprotozoal drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.3X5DAdverse effect of other antiprotozoal drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.3X5SAdverse effect of other antiprotozoal drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.3X6AUnderdosing of other antiprotozoal drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.3X6DUnderdosing of other antiprotozoal drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.3X6SUnderdosing of other antiprotozoal drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.4X5AAdverse effect of anthelminthics, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.4X5DAdverse effect of anthelminthics, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.4X5SAdverse effect of anthelminthics, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.4X6AUnderdosing of anthelminthics, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.4X6DUnderdosing of anthelminthics, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.4X6SUnderdosing of anthelminthics, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.5X5AAdverse effect of antiviral drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.5X5DAdverse effect of antiviral drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.5X5SAdverse effect of antiviral drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.5X6AUnderdosing of antiviral drugs, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.5X6DUnderdosing of antiviral drugs, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.5X6SUnderdosing of antiviral drugs, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.8X5AAdverse effect of other specified systemic anti-infectives and antiparasitics, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.8X6AUnderdosing of other specified systemic anti-infectives and antiparasitics, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.8X6DUnderdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.8X6SUnderdosing of other specified systemic anti-infectives and antiparasitics, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.95XAAdverse effect of unspecified systemic anti-infective and antiparasitic, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.95XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.95XSAdverse effect of unspecified systemic anti-infective and antiparasitic, sequelaSystemic anti- infectives and antiparasitics (T37)
T37.96XAUnderdosing of unspecified systemic anti-infectives and antiparasitics, initial encounterSystemic anti- infectives and antiparasitics (T37)
T37.96XDUnderdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounterSystemic anti- infectives and antiparasitics (T37)
T37.96XSUnderdosing of unspecified systemic anti-infectives and antiparasitics, sequelaSystemic anti- infectives and antiparasitics (T37)
T38.0X5AAdverse effect of glucocorticoids and synthetic analogues, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.0X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.0X5SAdverse effect of glucocorticoids and synthetic analogues, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.0X6AUnderdosing of glucocorticoids and synthetic analogues, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.0X6DUnderdosing of glucocorticoids and synthetic analogues, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.0X6SUnderdosing of glucocorticoids and synthetic analogues, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X5AAdverse effect of thyroid hormones and substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X5DAdverse effect of thyroid hormones and substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X5SAdverse effect of thyroid hormones and substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X6AUnderdosing of thyroid hormones and substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X6DUnderdosing of thyroid hormones and substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.1X6SUnderdosing of thyroid hormones and substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X5AAdverse effect of antithyroid drugs, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X5DAdverse effect of antithyroid drugs, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X5SAdverse effect of antithyroid drugs, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X6AUnderdosing of antithyroid drugs, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X6DUnderdosing of antithyroid drugs, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.2X6SUnderdosing of antithyroid drugs, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X5AAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X5DAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X5SAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X6AUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X6DUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.3X6SUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X5AAdverse effect of oral contraceptives, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X5DAdverse effect of oral contraceptives, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X5SAdverse effect of oral contraceptives, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X6AUnderdosing of oral contraceptives, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X6DUnderdosing of oral contraceptives, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.4X6SUnderdosing of oral contraceptives, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X5AAdverse effect of other estrogens and progestogens, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X5DAdverse effect of other estrogens and progestogens, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X5SAdverse effect of other estrogens and progestogens, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X6AUnderdosing of other estrogens and progestogens, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X6DUnderdosing of other estrogens and progestogens, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.5X6SUnderdosing of other estrogens and progestogens, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X5AAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X5SAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X6AUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X6DUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.6X6SUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X5AAdverse effect of androgens and anabolic congeners, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X5DAdverse effect of androgens and anabolic congeners, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X5SAdverse effect of androgens and anabolic congeners, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X6AUnderdosing of androgens and anabolic congeners, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X6DUnderdosing of androgens and anabolic congeners, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.7X6SUnderdosing of androgens and anabolic congeners, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.805AAdverse effect of unspecified hormones and synthetic substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.805DAdverse effect of unspecified hormones and synthetic substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.805SAdverse effect of unspecified hormones and synthetic substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.806AUnderdosing of unspecified hormones and synthetic substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.806DUnderdosing of unspecified hormones and synthetic substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.806SUnderdosing of unspecified hormones and synthetic substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.815AAdverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.815DAdverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.815SAdverse effect of anterior pituitary [adenohypophyseal] hormones, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.816AUnderdosing of anterior pituitary [adenohypophyseal] hormones, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.816DUnderdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.816SUnderdosing of anterior pituitary [adenohypophyseal] hormones, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.895AAdverse effect of other hormones and synthetic substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.895DAdverse effect of other hormones and synthetic substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.895SAdverse effect of other hormones and synthetic substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.896AUnderdosing of other hormones and synthetic substitutes, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.896DUnderdosing of other hormones and synthetic substitutes, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.896SUnderdosing of other hormones and synthetic substitutes, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.905AAdverse effect of unspecified hormone antagonists, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.905DAdverse effect of unspecified hormone antagonists, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.905SAdverse effect of unspecified hormone antagonists, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.906AUnderdosing of unspecified hormone antagonists, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.906DUnderdosing of unspecified hormone antagonists, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.906SUnderdosing of unspecified hormone antagonists, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.995AAdverse effect of other hormone antagonists, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.995DAdverse effect of other hormone antagonists, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.995SAdverse effect of other hormone antagonists, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T38.996AUnderdosing of other hormone antagonists, initial encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.996DUnderdosing of other hormone antagonists, subsequent encounterHormones and their synthetic substitutes and antag, NEC (T38)
T38.996SUnderdosing of other hormone antagonists, sequelaHormones and their synthetic substitutes and antag, NEC (T38)
T39.015AAdverse effect of aspirin, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.015DAdverse effect of aspirin, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.015SAdverse effect of aspirin, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.016AUnderdosing of aspirin, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.016DUnderdosing of aspirin, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.016SUnderdosing of aspirin, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.095AAdverse effect of salicylates, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.095DAdverse effect of salicylates, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.095SAdverse effect of salicylates, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.096AUnderdosing of salicylates, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.096DUnderdosing of salicylates, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.096SUnderdosing of salicylates, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X5AAdverse effect of 4-Aminophenol derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X5SAdverse effect of 4-Aminophenol derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X6AUnderdosing of 4-Aminophenol derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X6DUnderdosing of 4-Aminophenol derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.1X6SUnderdosing of 4-Aminophenol derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X5AAdverse effect of pyrazolone derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X5DAdverse effect of pyrazolone derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X5SAdverse effect of pyrazolone derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X6AUnderdosing of pyrazolone derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X6DUnderdosing of pyrazolone derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.2X6SUnderdosing of pyrazolone derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.315AAdverse effect of propionic acid derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.315DAdverse effect of propionic acid derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.315SAdverse effect of propionic acid derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.316AUnderdosing of propionic acid derivatives, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.316DUnderdosing of propionic acid derivatives, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.316SUnderdosing of propionic acid derivatives, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.395AAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.395SAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.396AUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.396DUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.396SUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X5AAdverse effect of antirheumatics, not elsewhere classified, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X5DAdverse effect of antirheumatics, not elsewhere classified, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X5SAdverse effect of antirheumatics, not elsewhere classified, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X6AUnderdosing of antirheumatics, not elsewhere classified, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X6DUnderdosing of antirheumatics, not elsewhere classified, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.4X6SUnderdosing of antirheumatics, not elsewhere classified, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X5AAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X5DAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X5SAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X6AUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X6DUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.8X6SUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.95XAAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.95XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.95XSAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.96XAUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.96XDUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounterNonopioid analgesics, antipyretics and antirheumatics (T39)
T39.96XSUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequelaNonopioid analgesics, antipyretics and antirheumatics (T39)
T40.0X5AAdverse effect of opium, initial encounterNarcotics and psychodysleptics (T40)
T40.0X5DAdverse effect of opium, subsequent encounterNarcotics and psychodysleptics (T40)
T40.0X5SAdverse effect of opium, sequelaNarcotics and psychodysleptics (T40)
T40.0X6AUnderdosing of opium, initial encounterNarcotics and psychodysleptics (T40)
T40.0X6DUnderdosing of opium, subsequent encounterNarcotics and psychodysleptics (T40)
T40.0X6SUnderdosing of opium, sequelaNarcotics and psychodysleptics (T40)
T40.2X5AAdverse effect of other opioids, initial encounterNarcotics and psychodysleptics (T40)
T40.2X5DAdverse effect of other opioids, subsequent encounterNarcotics and psychodysleptics (T40)
T40.2X5SAdverse effect of other opioids, sequelaNarcotics and psychodysleptics (T40)
T40.2X6AUnderdosing of other opioids, initial encounterNarcotics and psychodysleptics (T40)
T40.2X6DUnderdosing of other opioids, subsequent encounterNarcotics and psychodysleptics (T40)
T40.2X6SUnderdosing of other opioids, sequelaNarcotics and psychodysleptics (T40)
T40.3X5AAdverse effect of methadone, initial encounterNarcotics and psychodysleptics (T40)
T40.3X5DAdverse effect of methadone, subsequent encounterNarcotics and psychodysleptics (T40)
T40.3X5SAdverse effect of methadone, sequelaNarcotics and psychodysleptics (T40)
T40.3X6AUnderdosing of methadone, initial encounterNarcotics and psychodysleptics (T40)
T40.3X6DUnderdosing of methadone, subsequent encounterNarcotics and psychodysleptics (T40)
T40.3X6SUnderdosing of methadone, sequelaNarcotics and psychodysleptics (T40)
T40.4X5AAdverse effect of other synthetic narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.4X5DAdverse effect of other synthetic narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.4X5SAdverse effect of other synthetic narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.4X6AUnderdosing of other synthetic narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.4X6DUnderdosing of other synthetic narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.4X6SUnderdosing of other synthetic narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.5X5AAdverse effect of cocaine, initial encounterNarcotics and psychodysleptics (T40)
T40.5X5DAdverse effect of cocaine, subsequent encounterNarcotics and psychodysleptics (T40)
T40.5X5SAdverse effect of cocaine, sequelaNarcotics and psychodysleptics (T40)
T40.5X6AUnderdosing of cocaine, initial encounterNarcotics and psychodysleptics (T40)
T40.5X6DUnderdosing of cocaine, subsequent encounterNarcotics and psychodysleptics (T40)
T40.5X6SUnderdosing of cocaine, sequelaNarcotics and psychodysleptics (T40)
T40.605AAdverse effect of unspecified narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.605DAdverse effect of unspecified narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.605SAdverse effect of unspecified narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.606AUnderdosing of unspecified narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.606DUnderdosing of unspecified narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.606SUnderdosing of unspecified narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.695AAdverse effect of other narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.695DAdverse effect of other narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.695SAdverse effect of other narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.696AUnderdosing of other narcotics, initial encounterNarcotics and psychodysleptics (T40)
T40.696DUnderdosing of other narcotics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.696SUnderdosing of other narcotics, sequelaNarcotics and psychodysleptics (T40)
T40.7X5AAdverse effect of cannabis (derivatives), initial encounterNarcotics and psychodysleptics (T40)
T40.7X5DAdverse effect of cannabis (derivatives), subsequent encounterNarcotics and psychodysleptics (T40)
T40.7X5SAdverse effect of cannabis (derivatives), sequelaNarcotics and psychodysleptics (T40)
T40.7X6AUnderdosing of cannabis (derivatives), initial encounterNarcotics and psychodysleptics (T40)
T40.7X6DUnderdosing of cannabis (derivatives), subsequent encounterNarcotics and psychodysleptics (T40)
T40.7X6SUnderdosing of cannabis (derivatives), sequelaNarcotics and psychodysleptics (T40)
T40.905AAdverse effect of unspecified psychodysleptics [hallucinogens], initial encounterNarcotics and psychodysleptics (T40)
T40.905DAdverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounterNarcotics and psychodysleptics (T40)
T40.905SAdverse effect of unspecified psychodysleptics [hallucinogens], sequelaNarcotics and psychodysleptics (T40)
T40.906AUnderdosing of unspecified psychodysleptics, initial encounterNarcotics and psychodysleptics (T40)
T40.906DUnderdosing of unspecified psychodysleptics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.906SUnderdosing of unspecified psychodysleptics, sequelaNarcotics and psychodysleptics (T40)
T40.995AAdverse effect of other psychodysleptics [hallucinogens], initial encounterNarcotics and psychodysleptics (T40)
T40.995DAdverse effect of other psychodysleptics [hallucinogens], subsequent encounterNarcotics and psychodysleptics (T40)
T40.995SAdverse effect of other psychodysleptics [hallucinogens], sequelaNarcotics and psychodysleptics (T40)
T40.996AUnderdosing of other psychodysleptics, initial encounterNarcotics and psychodysleptics (T40)
T40.996DUnderdosing of other psychodysleptics, subsequent encounterNarcotics and psychodysleptics (T40)
T40.996SUnderdosing of other psychodysleptics, sequelaNarcotics and psychodysleptics (T40)
T41.0X5AAdverse effect of inhaled anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.0X5DAdverse effect of inhaled anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.0X5SAdverse effect of inhaled anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.0X6AUnderdosing of inhaled anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.0X6DUnderdosing of inhaled anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.0X6SUnderdosing of inhaled anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.1X5AAdverse effect of intravenous anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.1X5DAdverse effect of intravenous anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.1X5SAdverse effect of intravenous anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.1X6AUnderdosing of intravenous anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.1X6DUnderdosing of intravenous anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.1X6SUnderdosing of intravenous anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.205AAdverse effect of unspecified general anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.205DAdverse effect of unspecified general anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.205SAdverse effect of unspecified general anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.206AUnderdosing of unspecified general anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.206DUnderdosing of unspecified general anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.206SUnderdosing of unspecified general anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.295AAdverse effect of other general anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.295DAdverse effect of other general anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.295SAdverse effect of other general anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.296AUnderdosing of other general anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.296DUnderdosing of other general anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.296SUnderdosing of other general anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.3X5AAdverse effect of local anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.3X5DAdverse effect of local anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.3X5SAdverse effect of local anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.3X6AUnderdosing of local anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.3X6DUnderdosing of local anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.3X6SUnderdosing of local anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.45XAAdverse effect of unspecified anesthetic, initial encounterAnesthetics and therapeutic gases (T41)
T41.45XDAdverse effect of unspecified anesthetic, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.45XSAdverse effect of unspecified anesthetic, sequelaAnesthetics and therapeutic gases (T41)
T41.46XAUnderdosing of unspecified anesthetics, initial encounterAnesthetics and therapeutic gases (T41)
T41.46XDUnderdosing of unspecified anesthetics, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.46XSUnderdosing of unspecified anesthetics, sequelaAnesthetics and therapeutic gases (T41)
T41.5X5AAdverse effect of therapeutic gases, initial encounterAnesthetics and therapeutic gases (T41)
T41.5X5DAdverse effect of therapeutic gases, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.5X5SAdverse effect of therapeutic gases, sequelaAnesthetics and therapeutic gases (T41)
T41.5X6AUnderdosing of therapeutic gases, initial encounterAnesthetics and therapeutic gases (T41)
T41.5X6DUnderdosing of therapeutic gases, subsequent encounterAnesthetics and therapeutic gases (T41)
T41.5X6SUnderdosing of therapeutic gases, sequelaAnesthetics and therapeutic gases (T41)
T42.0X5AAdverse effect of hydantoin derivatives, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.0X5DAdverse effect of hydantoin derivatives, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.0X5SAdverse effect of hydantoin derivatives, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.0X6AUnderdosing of hydantoin derivatives, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.0X6DUnderdosing of hydantoin derivatives, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.0X6SUnderdosing of hydantoin derivatives, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X5AAdverse effect of iminostilbenes, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X5DAdverse effect of iminostilbenes, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X5SAdverse effect of iminostilbenes, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X6AUnderdosing of iminostilbenes, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X6DUnderdosing of iminostilbenes, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.1X6SUnderdosing of iminostilbenes, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X5AAdverse effect of succinimides and oxazolidinediones, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X5DAdverse effect of succinimides and oxazolidinediones, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X5SAdverse effect of succinimides and oxazolidinediones, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X6AUnderdosing of succinimides and oxazolidinediones, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X6DUnderdosing of succinimides and oxazolidinediones, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.2X6SUnderdosing of succinimides and oxazolidinediones, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X5AAdverse effect of barbiturates, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X5DAdverse effect of barbiturates, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X5SAdverse effect of barbiturates, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X6AUnderdosing of barbiturates, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X6DUnderdosing of barbiturates, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.3X6SUnderdosing of barbiturates, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X5AAdverse effect of benzodiazepines, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X5DAdverse effect of benzodiazepines, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X5SAdverse effect of benzodiazepines, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X6AUnderdosing of benzodiazepines, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X6DUnderdosing of benzodiazepines, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.4X6SUnderdosing of benzodiazepines, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X5AAdverse effect of mixed antiepileptics, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X5DAdverse effect of mixed antiepileptics, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X5SAdverse effect of mixed antiepileptics, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X6AUnderdosing of mixed antiepileptics, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X6DUnderdosing of mixed antiepileptics, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.5X6SUnderdosing of mixed antiepileptics, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X5DAdverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X5SAdverse effect of other antiepileptic and sedative-hypnotic drugs, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X6AUnderdosing of other antiepileptic and sedative-hypnotic drugs, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X6DUnderdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.6X6SUnderdosing of other antiepileptic and sedative-hypnotic drugs, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.75XAAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.75XDAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.75XSAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.76XAUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.76XDUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.76XSUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X5AAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X5DAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X5SAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X6AUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X6DUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounterAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T42.8X6SUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequelaAntiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42)
T43.015AAdverse effect of tricyclic antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.015DAdverse effect of tricyclic antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.015SAdverse effect of tricyclic antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.016AUnderdosing of tricyclic antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.016DUnderdosing of tricyclic antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.016SUnderdosing of tricyclic antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.025AAdverse effect of tetracyclic antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.025DAdverse effect of tetracyclic antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.025SAdverse effect of tetracyclic antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.026AUnderdosing of tetracyclic antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.026DUnderdosing of tetracyclic antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.026SUnderdosing of tetracyclic antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.1X5AAdverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.1X5DAdverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.1X5SAdverse effect of monoamine-oxidase-inhibitor antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.1X6AUnderdosing of monoamine-oxidase-inhibitor antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.1X6DUnderdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.1X6SUnderdosing of monoamine-oxidase-inhibitor antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.205AAdverse effect of unspecified antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.205DAdverse effect of unspecified antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.205SAdverse effect of unspecified antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.206AUnderdosing of unspecified antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.206DUnderdosing of unspecified antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.206SUnderdosing of unspecified antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.215AAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.215DAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.215SAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.216AUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.216DUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.216SUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.225AAdverse effect of selective serotonin reuptake inhibitors, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.225DAdverse effect of selective serotonin reuptake inhibitors, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.225SAdverse effect of selective serotonin reuptake inhibitors, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.226AUnderdosing of selective serotonin reuptake inhibitors, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.226DUnderdosing of selective serotonin reuptake inhibitors, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.226SUnderdosing of selective serotonin reuptake inhibitors, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.295AAdverse effect of other antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.295DAdverse effect of other antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.295SAdverse effect of other antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.296AUnderdosing of other antidepressants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.296DUnderdosing of other antidepressants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.296SUnderdosing of other antidepressants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.3X5AAdverse effect of phenothiazine antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.3X5DAdverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.3X5SAdverse effect of phenothiazine antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.3X6AUnderdosing of phenothiazine antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.3X6DUnderdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.3X6SUnderdosing of phenothiazine antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.4X5AAdverse effect of butyrophenone and thiothixene neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.4X5DAdverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.4X5SAdverse effect of butyrophenone and thiothixene neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.4X6AUnderdosing of butyrophenone and thiothixene neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.4X6DUnderdosing of butyrophenone and thiothixene neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.4X6SUnderdosing of butyrophenone and thiothixene neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.505AAdverse effect of unspecified antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.505DAdverse effect of unspecified antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.505SAdverse effect of unspecified antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.506AUnderdosing of unspecified antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.506DUnderdosing of unspecified antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.506SUnderdosing of unspecified antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.595AAdverse effect of other antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.595DAdverse effect of other antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.595SAdverse effect of other antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.596AUnderdosing of other antipsychotics and neuroleptics, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.596DUnderdosing of other antipsychotics and neuroleptics, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.596SUnderdosing of other antipsychotics and neuroleptics, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.605AAdverse effect of unspecified psychostimulants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.605DAdverse effect of unspecified psychostimulants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.605SAdverse effect of unspecified psychostimulants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.606AUnderdosing of unspecified psychostimulants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.606DUnderdosing of unspecified psychostimulants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.606SUnderdosing of unspecified psychostimulants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.615AAdverse effect of caffeine, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.615DAdverse effect of caffeine, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.615SAdverse effect of caffeine, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.616AUnderdosing of caffeine, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.616DUnderdosing of caffeine, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.616SUnderdosing of caffeine, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.625AAdverse effect of amphetamines, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.625DAdverse effect of amphetamines, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.625SAdverse effect of amphetamines, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.626AUnderdosing of amphetamines, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.626DUnderdosing of amphetamines, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.626SUnderdosing of amphetamines, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.635AAdverse effect of methylphenidate, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.635DAdverse effect of methylphenidate, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.635SAdverse effect of methylphenidate, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.636AUnderdosing of methylphenidate, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.636DUnderdosing of methylphenidate, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.636SUnderdosing of methylphenidate, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.695AAdverse effect of other psychostimulants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.695DAdverse effect of other psychostimulants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.695SAdverse effect of other psychostimulants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.696AUnderdosing of other psychostimulants, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.696DUnderdosing of other psychostimulants, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.696SUnderdosing of other psychostimulants, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.8X5AAdverse effect of other psychotropic drugs, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.8X5DAdverse effect of other psychotropic drugs, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.8X5SAdverse effect of other psychotropic drugs, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.8X6AUnderdosing of other psychotropic drugs, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.8X6DUnderdosing of other psychotropic drugs, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.8X6SUnderdosing of other psychotropic drugs, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.95XAAdverse effect of unspecified psychotropic drug, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.95XDAdverse effect of unspecified psychotropic drug, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.95XSAdverse effect of unspecified psychotropic drug, sequelaPsychotropic drugs, not elsewhere classified (T43)
T43.96XAUnderdosing of unspecified psychotropic drug, initial encounterPsychotropic drugs, not elsewhere classified (T43)
T43.96XDUnderdosing of unspecified psychotropic drug, subsequent encounterPsychotropic drugs, not elsewhere classified (T43)
T43.96XSUnderdosing of unspecified psychotropic drug, sequelaPsychotropic drugs, not elsewhere classified (T43)
T44.0X5AAdverse effect of anticholinesterase agents, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.0X5DAdverse effect of anticholinesterase agents, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.0X5SAdverse effect of anticholinesterase agents, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.0X6AUnderdosing of anticholinesterase agents, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.0X6DUnderdosing of anticholinesterase agents, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.0X6SUnderdosing of anticholinesterase agents, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.1X5AAdverse effect of other parasympathomimetics [cholinergics], initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.1X5DAdverse effect of other parasympathomimetics [cholinergics], subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.1X5SAdverse effect of other parasympathomimetics [cholinergics], sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.1X6AUnderdosing of other parasympathomimetics, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.1X6DUnderdosing of other parasympathomimetics, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.1X6SUnderdosing of other parasympathomimetics, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.2X5AAdverse effect of ganglionic blocking drugs, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.2X5DAdverse effect of ganglionic blocking drugs, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.2X5SAdverse effect of ganglionic blocking drugs, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.2X6AUnderdosing of ganglionic blocking drugs, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.2X6DUnderdosing of ganglionic blocking drugs, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.2X6SUnderdosing of ganglionic blocking drugs, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.3X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.3X6AUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.3X6DUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.3X6SUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.4X5AAdverse effect of predominantly alpha-adrenoreceptor agonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.4X5DAdverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.4X5SAdverse effect of predominantly alpha-adrenoreceptor agonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.4X6AUnderdosing of predominantly alpha-adrenoreceptor agonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.4X6DUnderdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.4X6SUnderdosing of predominantly alpha-adrenoreceptor agonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.5X5AAdverse effect of predominantly beta-adrenoreceptor agonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.5X6AUnderdosing of predominantly beta-adrenoreceptor agonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.5X6DUnderdosing of predominantly beta-adrenoreceptor agonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.5X6SUnderdosing of predominantly beta-adrenoreceptor agonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.6X5AAdverse effect of alpha-adrenoreceptor antagonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.6X5DAdverse effect of alpha-adrenoreceptor antagonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.6X5SAdverse effect of alpha-adrenoreceptor antagonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.6X6AUnderdosing of alpha-adrenoreceptor antagonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.6X6DUnderdosing of alpha-adrenoreceptor antagonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.6X6SUnderdosing of alpha-adrenoreceptor antagonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.7X5AAdverse effect of beta-adrenoreceptor antagonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.7X5DAdverse effect of beta-adrenoreceptor antagonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.7X5SAdverse effect of beta-adrenoreceptor antagonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.7X6AUnderdosing of beta-adrenoreceptor antagonists, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.7X6DUnderdosing of beta-adrenoreceptor antagonists, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.7X6SUnderdosing of beta-adrenoreceptor antagonists, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.8X5AAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.8X5DAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.8X5SAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.8X6AUnderdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.8X6DUnderdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.8X6SUnderdosing of centrally-acting and adrenergic-neuron-blocking agents, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.905AAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.905DAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.905SAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.906AUnderdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.906DUnderdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.906SUnderdosing of unspecified drugs primarily affecting the autonomic nervous system, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.995AAdverse effect of other drug primarily affecting the autonomic nervous system, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.995DAdverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.995SAdverse effect of other drug primarily affecting the autonomic nervous system, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T44.996AUnderdosing of other drug primarily affecting the autonomic nervous system, initial encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.996DUnderdosing of other drug primarily affecting the autonomic nervous system, subsequent encounterDrugs primarily affecting the autonomic nervous system (T44)
T44.996SUnderdosing of other drug primarily affecting the autonomic nervous system, sequelaDrugs primarily affecting the autonomic nervous system (T44)
T45.0X5AAdverse effect of antiallergic and antiemetic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.0X5DAdverse effect of antiallergic and antiemetic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.0X5SAdverse effect of antiallergic and antiemetic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.0X6AUnderdosing of antiallergic and antiemetic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.0X6DUnderdosing of antiallergic and antiemetic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.0X6SUnderdosing of antiallergic and antiemetic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.1X6AUnderdosing of antineoplastic and immunosuppressive drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.1X6DUnderdosing of antineoplastic and immunosuppressive drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.1X6SUnderdosing of antineoplastic and immunosuppressive drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.2X5AAdverse effect of vitamins, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.2X5DAdverse effect of vitamins, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.2X5SAdverse effect of vitamins, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.2X6AUnderdosing of vitamins, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.2X6DUnderdosing of vitamins, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.2X6SUnderdosing of vitamins, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.3X5AAdverse effect of enzymes, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.3X5DAdverse effect of enzymes, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.3X5SAdverse effect of enzymes, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.3X6AUnderdosing of enzymes, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.3X6DUnderdosing of enzymes, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.3X6SUnderdosing of enzymes, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.4X5AAdverse effect of iron and its compounds, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.4X5DAdverse effect of iron and its compounds, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.4X5SAdverse effect of iron and its compounds, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.4X6AUnderdosing of iron and its compounds, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.4X6DUnderdosing of iron and its compounds, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.4X6SUnderdosing of iron and its compounds, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.515AAdverse effect of anticoagulants, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.515DAdverse effect of anticoagulants, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.515SAdverse effect of anticoagulants, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.516AUnderdosing of anticoagulants, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.516DUnderdosing of anticoagulants, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.516SUnderdosing of anticoagulants, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.525AAdverse effect of antithrombotic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.525DAdverse effect of antithrombotic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.525SAdverse effect of antithrombotic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.526AUnderdosing of antithrombotic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.526DUnderdosing of antithrombotic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.526SUnderdosing of antithrombotic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.605AAdverse effect of unspecified fibrinolysis-affecting drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.605DAdverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.605SAdverse effect of unspecified fibrinolysis-affecting drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.606AUnderdosing of unspecified fibrinolysis-affecting drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.606DUnderdosing of unspecified fibrinolysis-affecting drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.606SUnderdosing of unspecified fibrinolysis-affecting drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.615AAdverse effect of thrombolytic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.615DAdverse effect of thrombolytic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.615SAdverse effect of thrombolytic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.616AUnderdosing of thrombolytic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.616DUnderdosing of thrombolytic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.616SUnderdosing of thrombolytic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.625AAdverse effect of hemostatic drug, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.625DAdverse effect of hemostatic drug, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.625SAdverse effect of hemostatic drug, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.626AUnderdosing of hemostatic drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.626DUnderdosing of hemostatic drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.626SUnderdosing of hemostatic drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.695AAdverse effect of other fibrinolysis-affecting drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.695DAdverse effect of other fibrinolysis-affecting drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.695SAdverse effect of other fibrinolysis-affecting drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.696AUnderdosing of other fibrinolysis-affecting drugs, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.696DUnderdosing of other fibrinolysis-affecting drugs, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.696SUnderdosing of other fibrinolysis-affecting drugs, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.7X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.7X5DAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.7X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.7X6AUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.7X6DUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.7X6SUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.8X5AAdverse effect of other primarily systemic and hematological agents, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.8X5DAdverse effect of other primarily systemic and hematological agents, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.8X5SAdverse effect of other primarily systemic and hematological agents, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.8X6AUnderdosing of other primarily systemic and hematological agents, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.8X6DUnderdosing of other primarily systemic and hematological agents, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.8X6SUnderdosing of other primarily systemic and hematological agents, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.95XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.95XDAdverse effect of unspecified primarily systemic and hematological agent, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.95XSAdverse effect of unspecified primarily systemic and hematological agent, sequelaPrimarily systemic and hematological agents, NEC (T45)
T45.96XAUnderdosing of unspecified primarily systemic and hematological agent, initial encounterPrimarily systemic and hematological agents, NEC (T45)
T45.96XDUnderdosing of unspecified primarily systemic and hematological agent, subsequent encounterPrimarily systemic and hematological agents, NEC (T45)
T45.96XSUnderdosing of unspecified primarily systemic and hematological agent, sequelaPrimarily systemic and hematological agents, NEC (T45)
T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.0X6AUnderdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.1X5AAdverse effect of calcium-channel blockers, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.1X5SAdverse effect of calcium-channel blockers, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.1X6AUnderdosing of calcium-channel blockers, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.1X6SUnderdosing of calcium-channel blockers, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.2X5SAdverse effect of other antidysrhythmic drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.2X6AUnderdosing of other antidysrhythmic drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.2X6SUnderdosing of other antidysrhythmic drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.3X5AAdverse effect of coronary vasodilators, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.3X5DAdverse effect of coronary vasodilators, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.3X5SAdverse effect of coronary vasodilators, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.3X6AUnderdosing of coronary vasodilators, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.3X6DUnderdosing of coronary vasodilators, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.3X6SUnderdosing of coronary vasodilators, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.4X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.4X6AUnderdosing of angiotensin-converting-enzyme inhibitors, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.4X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.4X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.5X5AAdverse effect of other antihypertensive drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.5X5SAdverse effect of other antihypertensive drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.5X6AUnderdosing of other antihypertensive drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.5X6DUnderdosing of other antihypertensive drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.5X6SUnderdosing of other antihypertensive drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.6X6AUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.7X5AAdverse effect of peripheral vasodilators, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.7X5SAdverse effect of peripheral vasodilators, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.7X6AUnderdosing of peripheral vasodilators, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.7X6DUnderdosing of peripheral vasodilators, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.7X6SUnderdosing of peripheral vasodilators, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.8X6AUnderdosing of antivaricose drugs, including sclerosing agents, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.906AUnderdosing of unspecified agents primarily affecting the cardiovascular system, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.906DUnderdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.906SUnderdosing of unspecified agents primarily affecting the cardiovascular system, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.995SAdverse effect of other agents primarily affecting the cardiovascular system, sequelaAgents primarily affecting the cardiovascular system (T46)
T46.996AUnderdosing of other agents primarily affecting the cardiovascular system, initial encounterAgents primarily affecting the cardiovascular system (T46)
T46.996DUnderdosing of other agents primarily affecting the cardiovascular system, subsequent encounterAgents primarily affecting the cardiovascular system (T46)
T46.996SUnderdosing of other agents primarily affecting the cardiovascular system, sequelaAgents primarily affecting the cardiovascular system (T46)
T47.0X5AAdverse effect of histamine H2-receptor blockers, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.0X5DAdverse effect of histamine H2-receptor blockers, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.0X5SAdverse effect of histamine H2-receptor blockers, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.0X6AUnderdosing of histamine H2-receptor blockers, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.0X6DUnderdosing of histamine H2-receptor blockers, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.0X6SUnderdosing of histamine H2-receptor blockers, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.1X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.1X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.1X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.1X6AUnderdosing of other antacids and anti-gastric-secretion drugs, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.1X6DUnderdosing of other antacids and anti-gastric-secretion drugs, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.1X6SUnderdosing of other antacids and anti-gastric-secretion drugs, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.2X5AAdverse effect of stimulant laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.2X5DAdverse effect of stimulant laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.2X5SAdverse effect of stimulant laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.2X6AUnderdosing of stimulant laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.2X6DUnderdosing of stimulant laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.2X6SUnderdosing of stimulant laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.3X5AAdverse effect of saline and osmotic laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.3X5DAdverse effect of saline and osmotic laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.3X5SAdverse effect of saline and osmotic laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.3X6AUnderdosing of saline and osmotic laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.3X6DUnderdosing of saline and osmotic laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.3X6SUnderdosing of saline and osmotic laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.4X5AAdverse effect of other laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.4X5DAdverse effect of other laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.4X5SAdverse effect of other laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.4X6AUnderdosing of other laxatives, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.4X6DUnderdosing of other laxatives, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.4X6SUnderdosing of other laxatives, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.5X5AAdverse effect of digestants, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.5X5DAdverse effect of digestants, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.5X5SAdverse effect of digestants, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.5X6AUnderdosing of digestants, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.5X6DUnderdosing of digestants, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.5X6SUnderdosing of digestants, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.6X5AAdverse effect of antidiarrheal drugs, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.6X5DAdverse effect of antidiarrheal drugs, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.6X5SAdverse effect of antidiarrheal drugs, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.6X6AUnderdosing of antidiarrheal drugs, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.6X6DUnderdosing of antidiarrheal drugs, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.6X6SUnderdosing of antidiarrheal drugs, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.7X5AAdverse effect of emetics, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.7X5DAdverse effect of emetics, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.7X5SAdverse effect of emetics, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.7X6AUnderdosing of emetics, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.7X6DUnderdosing of emetics, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.7X6SUnderdosing of emetics, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.8X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.8X5DAdverse effect of other agents primarily affecting gastrointestinal system, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.8X5SAdverse effect of other agents primarily affecting gastrointestinal system, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.8X6AUnderdosing of other agents primarily affecting gastrointestinal system, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.8X6DUnderdosing of other agents primarily affecting gastrointestinal system, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.8X6SUnderdosing of other agents primarily affecting gastrointestinal system, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.95XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.95XDAdverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.95XSAdverse effect of unspecified agents primarily affecting the gastrointestinal system, sequelaAgents primarily affecting the gastrointestinal system (T47)
T47.96XAUnderdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounterAgents primarily affecting the gastrointestinal system (T47)
T47.96XDUnderdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounterAgents primarily affecting the gastrointestinal system (T47)
T47.96XSUnderdosing of unspecified agents primarily affecting the gastrointestinal system, sequelaAgents primarily affecting the gastrointestinal system (T47)
T48.0X5AAdverse effect of oxytocic drugs, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.0X5DAdverse effect of oxytocic drugs, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.0X5SAdverse effect of oxytocic drugs, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.0X6AUnderdosing of oxytocic drugs, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.0X6DUnderdosing of oxytocic drugs, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.0X6SUnderdosing of oxytocic drugs, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X6AUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X6DUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.1X6SUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.205AAdverse effect of unspecified drugs acting on muscles, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.205DAdverse effect of unspecified drugs acting on muscles, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.205SAdverse effect of unspecified drugs acting on muscles, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.206AUnderdosing of unspecified drugs acting on muscles, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.206DUnderdosing of unspecified drugs acting on muscles, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.206SUnderdosing of unspecified drugs acting on muscles, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.295AAdverse effect of other drugs acting on muscles, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.295DAdverse effect of other drugs acting on muscles, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.295SAdverse effect of other drugs acting on muscles, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.296AUnderdosing of other drugs acting on muscles, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.296DUnderdosing of other drugs acting on muscles, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.296SUnderdosing of other drugs acting on muscles, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X5AAdverse effect of antitussives, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X5DAdverse effect of antitussives, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X5SAdverse effect of antitussives, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X6AUnderdosing of antitussives, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X6DUnderdosing of antitussives, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.3X6SUnderdosing of antitussives, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X5AAdverse effect of expectorants, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X5DAdverse effect of expectorants, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X5SAdverse effect of expectorants, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X6AUnderdosing of expectorants, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X6DUnderdosing of expectorants, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.4X6SUnderdosing of expectorants, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X5AAdverse effect of other anti-common-cold drugs, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X5DAdverse effect of other anti-common-cold drugs, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X5SAdverse effect of other anti-common-cold drugs, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X6AUnderdosing of other anti-common-cold drugs, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X6DUnderdosing of other anti-common-cold drugs, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.5X6SUnderdosing of other anti-common-cold drugs, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X5AAdverse effect of antiasthmatics, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X5DAdverse effect of antiasthmatics, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X5SAdverse effect of antiasthmatics, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X6AUnderdosing of antiasthmatics, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X6DUnderdosing of antiasthmatics, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.6X6SUnderdosing of antiasthmatics, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.905AAdverse effect of unspecified agents primarily acting on the respiratory system, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.905DAdverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.905SAdverse effect of unspecified agents primarily acting on the respiratory system, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.906AUnderdosing of unspecified agents primarily acting on the respiratory system, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.906DUnderdosing of unspecified agents primarily acting on the respiratory system, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.906SUnderdosing of unspecified agents primarily acting on the respiratory system, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.995AAdverse effect of other agents primarily acting on the respiratory system, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.995DAdverse effect of other agents primarily acting on the respiratory system, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.995SAdverse effect of other agents primarily acting on the respiratory system, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.996AUnderdosing of other agents primarily acting on the respiratory system, initial encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.996DUnderdosing of other agents primarily acting on the respiratory system, subsequent encounterAgents prim act on smooth and skeletal musc and the resp sys (T48)
T48.996SUnderdosing of other agents primarily acting on the respiratory system, sequelaAgents prim act on smooth and skeletal musc and the resp sys (T48)
T49.0X5AAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.0X5DAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.0X5SAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.0X6AUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.0X6DUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.0X6SUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.1X5AAdverse effect of antipruritics, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.1X5DAdverse effect of antipruritics, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.1X5SAdverse effect of antipruritics, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.1X6AUnderdosing of antipruritics, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.1X6DUnderdosing of antipruritics, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.1X6SUnderdosing of antipruritics, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.2X5AAdverse effect of local astringents and local detergents, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.2X5DAdverse effect of local astringents and local detergents, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.2X5SAdverse effect of local astringents and local detergents, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.2X6AUnderdosing of local astringents and local detergents, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.2X6DUnderdosing of local astringents and local detergents, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.2X6SUnderdosing of local astringents and local detergents, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.3X5AAdverse effect of emollients, demulcents and protectants, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.3X5DAdverse effect of emollients, demulcents and protectants, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.3X5SAdverse effect of emollients, demulcents and protectants, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.3X6AUnderdosing of emollients, demulcents and protectants, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.3X6DUnderdosing of emollients, demulcents and protectants, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.3X6SUnderdosing of emollients, demulcents and protectants, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.4X5AAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.4X5DAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.4X5SAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.4X6AUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.4X6DUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.4X6SUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.5X5AAdverse effect of ophthalmological drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.5X5DAdverse effect of ophthalmological drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.5X5SAdverse effect of ophthalmological drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.5X6AUnderdosing of ophthalmological drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.5X6DUnderdosing of ophthalmological drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.5X6SUnderdosing of ophthalmological drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.6X5AAdverse effect of otorhinolaryngological drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.6X5DAdverse effect of otorhinolaryngological drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.6X5SAdverse effect of otorhinolaryngological drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.6X6AUnderdosing of otorhinolaryngological drugs and preparations, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.6X6DUnderdosing of otorhinolaryngological drugs and preparations, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.6X6SUnderdosing of otorhinolaryngological drugs and preparations, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.7X5AAdverse effect of dental drugs, topically applied, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.7X5DAdverse effect of dental drugs, topically applied, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.7X5SAdverse effect of dental drugs, topically applied, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.7X6AUnderdosing of dental drugs, topically applied, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.7X6DUnderdosing of dental drugs, topically applied, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.7X6SUnderdosing of dental drugs, topically applied, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.8X5AAdverse effect of other topical agents, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.8X5DAdverse effect of other topical agents, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.8X5SAdverse effect of other topical agents, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.8X6AUnderdosing of other topical agents, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.8X6DUnderdosing of other topical agents, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.8X6SUnderdosing of other topical agents, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.95XAAdverse effect of unspecified topical agent, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.95XDAdverse effect of unspecified topical agent, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.95XSAdverse effect of unspecified topical agent, sequelaTopical skin/eye/ENT/dental drugs (T49)
T49.96XAUnderdosing of unspecified topical agent, initial encounterTopical skin/eye/ENT/dental drugs (T49)
T49.96XDUnderdosing of unspecified topical agent, subsequent encounterTopical skin/eye/ENT/dental drugs (T49)
T49.96XSUnderdosing of unspecified topical agent, sequelaTopical skin/eye/ENT/dental drugs (T49)
T50.0X5AAdverse effect of mineralocorticoids and their antagonists, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.0X6AUnderdosing of mineralocorticoids and their antagonists, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.0X6DUnderdosing of mineralocorticoids and their antagonists, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.0X6SUnderdosing of mineralocorticoids and their antagonists, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X5AAdverse effect of loop [high-ceiling] diuretics, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X5SAdverse effect of loop [high-ceiling] diuretics, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X6AUnderdosing of loop [high-ceiling] diuretics, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X6DUnderdosing of loop [high-ceiling] diuretics, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.1X6SUnderdosing of loop [high-ceiling] diuretics, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X5AAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X6AUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X6DUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.2X6SUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X5AAdverse effect of electrolytic, caloric and water-balance agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X5DAdverse effect of electrolytic, caloric and water-balance agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X5SAdverse effect of electrolytic, caloric and water-balance agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X6AUnderdosing of electrolytic, caloric and water-balance agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X6DUnderdosing of electrolytic, caloric and water-balance agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.3X6SUnderdosing of electrolytic, caloric and water-balance agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X5AAdverse effect of drugs affecting uric acid metabolism, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X5DAdverse effect of drugs affecting uric acid metabolism, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X5SAdverse effect of drugs affecting uric acid metabolism, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X6AUnderdosing of drugs affecting uric acid metabolism, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X6DUnderdosing of drugs affecting uric acid metabolism, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.4X6SUnderdosing of drugs affecting uric acid metabolism, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X5AAdverse effect of appetite depressants, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X5DAdverse effect of appetite depressants, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X5SAdverse effect of appetite depressants, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X6AUnderdosing of appetite depressants, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X6DUnderdosing of appetite depressants, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.5X6SUnderdosing of appetite depressants, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X5AAdverse effect of antidotes and chelating agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X5DAdverse effect of antidotes and chelating agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X5SAdverse effect of antidotes and chelating agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X6AUnderdosing of antidotes and chelating agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X6DUnderdosing of antidotes and chelating agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.6X6SUnderdosing of antidotes and chelating agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X5AAdverse effect of analeptics and opioid receptor antagonists, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X5DAdverse effect of analeptics and opioid receptor antagonists, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X5SAdverse effect of analeptics and opioid receptor antagonists, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X6AUnderdosing of analeptics and opioid receptor antagonists, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X6DUnderdosing of analeptics and opioid receptor antagonists, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.7X6SUnderdosing of analeptics and opioid receptor antagonists, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X5AAdverse effect of diagnostic agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X5DAdverse effect of diagnostic agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X5SAdverse effect of diagnostic agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X6AUnderdosing of diagnostic agents, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X6DUnderdosing of diagnostic agents, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.8X6SUnderdosing of diagnostic agents, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A15AAdverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A15DAdverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A15SAdverse effect of pertussis vaccine, including combinations with a pertussis component, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A16AUnderdosing of pertussis vaccine, including combinations with a pertussis component, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A16DUnderdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A16SUnderdosing of pertussis vaccine, including combinations with a pertussis component, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A25AAdverse effect of mixed bacterial vaccines without a pertussis component, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A25DAdverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A25SAdverse effect of mixed bacterial vaccines without a pertussis component, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A26AUnderdosing of mixed bacterial vaccines without a pertussis component, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A26DUnderdosing of mixed bacterial vaccines without a pertussis component, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A26SUnderdosing of mixed bacterial vaccines without a pertussis component, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A95AAdverse effect of other bacterial vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A95DAdverse effect of other bacterial vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A95SAdverse effect of other bacterial vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A96AUnderdosing of other bacterial vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A96DUnderdosing of other bacterial vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.A96SUnderdosing of other bacterial vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B15AAdverse effect of smallpox vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B15DAdverse effect of smallpox vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B15SAdverse effect of smallpox vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B16AUnderdosing of smallpox vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B16DUnderdosing of smallpox vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B16SUnderdosing of smallpox vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B95AAdverse effect of other viral vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B95DAdverse effect of other viral vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B95SAdverse effect of other viral vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B96AUnderdosing of other viral vaccines, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B96DUnderdosing of other viral vaccines, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.B96SUnderdosing of other viral vaccines, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z15AAdverse effect of immunoglobulin, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z15DAdverse effect of immunoglobulin, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z15SAdverse effect of immunoglobulin, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z16AUnderdosing of immunoglobulin, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z16DUnderdosing of immunoglobulin, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z16SUnderdosing of immunoglobulin, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z95AAdverse effect of other vaccines and biological substances, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z95DAdverse effect of other vaccines and biological substances, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z95SAdverse effect of other vaccines and biological substances, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z96AUnderdosing of other vaccines and biological substances, initial encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z96DUnderdosing of other vaccines and biological substances, subsequent encounterDiuretics and oth and unsp drug/meds/biol subst (T50)
T50.Z96SUnderdosing of other vaccines and biological substances, sequelaDiuretics and oth and unsp drug/meds/biol subst (T50)
T81.12XAPostprocedural septic shock, initial encounterComplications of procedures, not elsewhere classified (T81)
T81.12XDPostprocedural septic shock, subsequent encounterComplications of procedures, not elsewhere classified (T81)
T81.12XSPostprocedural septic shock, sequelaComplications of procedures, not elsewhere classified (T81)
Z00.00Encounter for general adult medical examination without abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.01Encounter for general adult medical examination with abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.110Health examination for newborn under 8 days oldEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.111Health examination for newborn 8 to 28 days oldEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.121Encounter for routine child health examination with abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.129Encounter for routine child health examination without abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.2Encounter for examination for period of rapid growth in childhoodEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.3Encounter for examination for adolescent development stateEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.5Encounter for examination of potential donor of organ and tissueEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.70Encounter for examination for period of delayed growth in childhood without abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.71Encounter for examination for period of delayed growth in childhood with abnormal findingsEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z00.8Encounter for other general examinationEncntr for general exam w/o complaint, susp or reprtd dx (Z00)
Z01.10Encounter for examination of ears and hearing without abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.110Encounter for hearing examination following failed hearing screeningEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.118Encounter for examination of ears and hearing with other abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.12Encounter for hearing conservation and treatmentEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.20Encounter for dental examination and cleaning without abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.21Encounter for dental examination and cleaning with abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.30Encounter for examination of blood pressure without abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.31Encounter for examination of blood pressure with abnormal findingsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.812Encounter for preprocedural laboratory examinationEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.818Encounter for other preprocedural examinationEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.82Encounter for allergy testingEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.83Encounter for blood typingEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.84Encounter for antibody response examinationEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z01.89Encounter for other specified special examinationsEncntr for oth sp exam w/o complaint, suspected or reprtd dx (Z01)
Z02.0Encounter for examination for admission to educational institutionEncounter for administrative examination (Z02)
Z02.2Encounter for examination for admission to residential institutionEncounter for administrative examination (Z02)
Z02.4Encounter for examination for driving licenseEncounter for administrative examination (Z02)
Z02.5Encounter for examination for participation in sportEncounter for administrative examination (Z02)
Z02.6Encounter for examination for insurance purposesEncounter for administrative examination (Z02)
Z02.71Encounter for disability determinationEncounter for administrative examination (Z02)
Z02.79Encounter for issue of other medical certificateEncounter for administrative examination (Z02)
Z02.82Encounter for adoption servicesEncounter for administrative examination (Z02)
Z02.89Encounter for other administrative examinationsEncounter for administrative examination (Z02)
Z02.9Encounter for administrative examinations, unspecifiedEncounter for administrative examination (Z02)
Z03.71Encounter for suspected problem with amniotic cavity and membrane ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z03.72Encounter for suspected placental problem ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z03.73Encounter for suspected fetal anomaly ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z03.74Encounter for suspected problem with fetal growth ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z03.75Encounter for suspected cervical shortening ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z03.79Encounter for other suspected maternal and fetal conditions ruled outEncntr for medical obs for susp diseases and cond ruled out (Z03)
Z04.9Encounter for examination and observation for unspecified reasonEncounter for examination and observation for other reasons (Z04)
Z08Encounter for follow-up examination after completed treatment for malignant neoplasmEncntr for follow-up exam after trtmt for malignant neoplasm (Z08)
Z09Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasmEncntr for f/u exam aft trtmt for cond oth than malig neoplm (Z09)
Z11.0Encounter for screening for intestinal infectious diseasesEncounter for screening for infec/parastc diseases (Z11)
Z11.1Encounter for screening for respiratory tuberculosisEncounter for screening for infec/parastc diseases (Z11)
Z11.2Encounter for screening for other bacterial diseasesEncounter for screening for infec/parastc diseases (Z11)
Z11.3Encounter for screening for infections with a predominantly sexual mode of transmissionEncounter for screening for infec/parastc diseases (Z11)
Z11.4Encounter for screening for human immunodeficiency virus [HIV]Encounter for screening for infec/parastc diseases (Z11)
Z11.51Encounter for screening for human papillomavirus (HPV)Encounter for screening for infec/parastc diseases (Z11)
Z11.59Encounter for screening for other viral diseasesEncounter for screening for infec/parastc diseases (Z11)
Z11.6Encounter for screening for other protozoal diseases and helminthiasesEncounter for screening for infec/parastc diseases (Z11)
Z11.8Encounter for screening for other infectious and parasitic diseasesEncounter for screening for infec/parastc diseases (Z11)
Z11.9Encounter for screening for infectious and parasitic diseases, unspecifiedEncounter for screening for infec/parastc diseases (Z11)
Z12.0Encounter for screening for malignant neoplasm of stomachEncounter for screening for malignant neoplasms (Z12)
Z12.10Encounter for screening for malignant neoplasm of intestinal tract, unspecifiedEncounter for screening for malignant neoplasms (Z12)
Z12.11Encounter for screening for malignant neoplasm of colonEncounter for screening for malignant neoplasms (Z12)
Z12.12Encounter for screening for malignant neoplasm of rectumEncounter for screening for malignant neoplasms (Z12)
Z12.13Encounter for screening for malignant neoplasm of small intestineEncounter for screening for malignant neoplasms (Z12)
Z12.2Encounter for screening for malignant neoplasm of respiratory organsEncounter for screening for malignant neoplasms (Z12)
Z12.31Encounter for screening mammogram for malignant neoplasm of breastEncounter for screening for malignant neoplasms (Z12)
Z12.39Encounter for other screening for malignant neoplasm of breastEncounter for screening for malignant neoplasms (Z12)
Z12.4Encounter for screening for malignant neoplasm of cervixEncounter for screening for malignant neoplasms (Z12)
Z12.6Encounter for screening for malignant neoplasm of bladderEncounter for screening for malignant neoplasms (Z12)
Z12.71Encounter for screening for malignant neoplasm of testisEncounter for screening for malignant neoplasms (Z12)
Z12.72Encounter for screening for malignant neoplasm of vaginaEncounter for screening for malignant neoplasms (Z12)
Z12.73Encounter for screening for malignant neoplasm of ovaryEncounter for screening for malignant neoplasms (Z12)
Z12.79Encounter for screening for malignant neoplasm of other genitourinary organsEncounter for screening for malignant neoplasms (Z12)
Z12.81Encounter for screening for malignant neoplasm of oral cavityEncounter for screening for malignant neoplasms (Z12)
Z12.82Encounter for screening for malignant neoplasm of nervous systemEncounter for screening for malignant neoplasms (Z12)
Z12.83Encounter for screening for malignant neoplasm of skinEncounter for screening for malignant neoplasms (Z12)
Z12.89Encounter for screening for malignant neoplasm of other sitesEncounter for screening for malignant neoplasms (Z12)
Z12.9Encounter for screening for malignant neoplasm, site unspecifiedEncounter for screening for malignant neoplasms (Z12)
Z13.0Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismEncounter for screening for other diseases and disorders (Z13)
Z13.1Encounter for screening for diabetes mellitusEncounter for screening for other diseases and disorders (Z13)
Z13.21Encounter for screening for nutritional disorderEncounter for screening for other diseases and disorders (Z13)
Z13.220Encounter for screening for lipoid disordersEncounter for screening for other diseases and disorders (Z13)
Z13.228Encounter for screening for other metabolic disordersEncounter for screening for other diseases and disorders (Z13)
Z13.29Encounter for screening for other suspected endocrine disorderEncounter for screening for other diseases and disorders (Z13)
Z13.4Encounter for screening for certain developmental disorders in childhoodEncounter for screening for other diseases and disorders (Z13)
Z13.5Encounter for screening for eye and ear disordersEncounter for screening for other diseases and disorders (Z13)
Z13.6Encounter for screening for cardiovascular disordersEncounter for screening for other diseases and disorders (Z13)
Z13.71Encounter for nonprocreative screening for genetic disease carrier statusEncounter for screening for other diseases and disorders (Z13)
Z13.79Encounter for other screening for genetic and chromosomal anomaliesEncounter for screening for other diseases and disorders (Z13)
Z13.810Encounter for screening for upper gastrointestinal disorderEncounter for screening for other diseases and disorders (Z13)
Z13.811Encounter for screening for lower gastrointestinal disorderEncounter for screening for other diseases and disorders (Z13)
Z13.818Encounter for screening for other digestive system disordersEncounter for screening for other diseases and disorders (Z13)
Z13.820Encounter for screening for osteoporosisEncounter for screening for other diseases and disorders (Z13)
Z13.828Encounter for screening for other musculoskeletal disorderEncounter for screening for other diseases and disorders (Z13)
Z13.83Encounter for screening for respiratory disorder NECEncounter for screening for other diseases and disorders (Z13)
Z13.84Encounter for screening for dental disordersEncounter for screening for other diseases and disorders (Z13)
Z13.850Encounter for screening for traumatic brain injuryEncounter for screening for other diseases and disorders (Z13)
Z13.858Encounter for screening for other nervous system disordersEncounter for screening for other diseases and disorders (Z13)
Z13.88Encounter for screening for disorder due to exposure to contaminantsEncounter for screening for other diseases and disorders (Z13)
Z13.89Encounter for screening for other disorderEncounter for screening for other diseases and disorders (Z13)
Z13.9Encounter for screening, unspecifiedEncounter for screening for other diseases and disorders (Z13)
Z14.01Asymptomatic hemophilia A carrierGenetic carrier (Z14)
Z14.02Symptomatic hemophilia A carrierGenetic carrier (Z14)
Z14.1Cystic fibrosis carrierGenetic carrier (Z14)
Z14.8Genetic carrier of other diseaseGenetic carrier (Z14)
Z15.01Genetic susceptibility to malignant neoplasm of breastGenetic susceptibility to disease (Z15)
Z15.02Genetic susceptibility to malignant neoplasm of ovaryGenetic susceptibility to disease (Z15)
Z15.03Genetic susceptibility to malignant neoplasm of prostateGenetic susceptibility to disease (Z15)
Z15.04Genetic susceptibility to malignant neoplasm of endometriumGenetic susceptibility to disease (Z15)
Z15.09Genetic susceptibility to other malignant neoplasmGenetic susceptibility to disease (Z15)
Z15.81Genetic susceptibility to multiple endocrine neoplasia [MEN]Genetic susceptibility to disease (Z15)
Z15.89Genetic susceptibility to other diseaseGenetic susceptibility to disease (Z15)
Z16.10Resistance to unspecified beta lactam antibioticsResistance to antimicrobial drugs (Z16)
Z16.11Resistance to penicillinsResistance to antimicrobial drugs (Z16)
Z16.12Extended spectrum beta lactamase (ESBL) resistanceResistance to antimicrobial drugs (Z16)
Z16.19Resistance to other specified beta lactam antibioticsResistance to antimicrobial drugs (Z16)
Z16.20Resistance to unspecified antibioticResistance to antimicrobial drugs (Z16)
Z16.21Resistance to vancomycinResistance to antimicrobial drugs (Z16)
Z16.22Resistance to vancomycin related antibioticsResistance to antimicrobial drugs (Z16)
Z16.23Resistance to quinolones and fluoroquinolonesResistance to antimicrobial drugs (Z16)
Z16.24Resistance to multiple antibioticsResistance to antimicrobial drugs (Z16)
Z16.29Resistance to other single specified antibioticResistance to antimicrobial drugs (Z16)
Z16.30Resistance to unspecified antimicrobial drugsResistance to antimicrobial drugs (Z16)
Z16.31Resistance to antiparasitic drug(s)Resistance to antimicrobial drugs (Z16)
Z16.32Resistance to antifungal drug(s)Resistance to antimicrobial drugs (Z16)
Z16.33Resistance to antiviral drug(s)Resistance to antimicrobial drugs (Z16)
Z16.341Resistance to single antimycobacterial drugResistance to antimicrobial drugs (Z16)
Z16.342Resistance to multiple antimycobacterial drugsResistance to antimicrobial drugs (Z16)
Z16.35Resistance to multiple antimicrobial drugsResistance to antimicrobial drugs (Z16)
Z16.39Resistance to other specified antimicrobial drugResistance to antimicrobial drugs (Z16)
Z17.0Estrogen receptor positive status [ER+]Estrogen receptor status (Z17)
Z17.1Estrogen receptor negative status [ER-]Estrogen receptor status (Z17)
Z18.01Retained depleted uranium fragmentsRetained foreign body fragments (Z18)
Z18.09Other retained radioactive fragmentsRetained foreign body fragments (Z18)
Z18.10Retained metal fragments, unspecifiedRetained foreign body fragments (Z18)
Z18.11Retained magnetic metal fragmentsRetained foreign body fragments (Z18)
Z18.12Retained nonmagnetic metal fragmentsRetained foreign body fragments (Z18)
Z18.2Retained plastic fragmentsRetained foreign body fragments (Z18)
Z18.31Retained animal quills or spinesRetained foreign body fragments (Z18)
Z18.32Retained toothRetained foreign body fragments (Z18)
Z18.33Retained wood fragmentsRetained foreign body fragments (Z18)
Z18.39Other retained organic fragmentsRetained foreign body fragments (Z18)
Z18.81Retained glass fragmentsRetained foreign body fragments (Z18)
Z18.83Retained stone or crystalline fragmentsRetained foreign body fragments (Z18)
Z18.89Other specified retained foreign body fragmentsRetained foreign body fragments (Z18)
Z18.9Retained foreign body fragments, unspecified materialRetained foreign body fragments (Z18)
Z19.1Hormone sensitive malignancy statusHormone sensitivity malignancy status (Z19)
Z19.2Hormone resistant malignancy statusHormone sensitivity malignancy status (Z19)
Z20.09Contact with and (suspected) exposure to other intestinal infectious diseasesContact w and (suspected) exposure to communicable diseases (Z20)
Z20.1Contact with and (suspected) exposure to tuberculosisContact w and (suspected) exposure to communicable diseases (Z20)
Z20.2Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmissionContact w and (suspected) exposure to communicable diseases (Z20)
Z20.3Contact with and (suspected) exposure to rabiesContact w and (suspected) exposure to communicable diseases (Z20)
Z20.4Contact with and (suspected) exposure to rubellaContact w and (suspected) exposure to communicable diseases (Z20)
Z20.7Contact with and (suspected) exposure to pediculosis, acariasis and other infestationsContact w and (suspected) exposure to communicable diseases (Z20)
Z20.810Contact with and (suspected) exposure to anthraxContact w and (suspected) exposure to communicable diseases (Z20)
Z20.818Contact with and (suspected) exposure to other bacterial communicable diseasesContact w and (suspected) exposure to communicable diseases (Z20)
Z20.89Contact with and (suspected) exposure to other communicable diseasesContact w and (suspected) exposure to communicable diseases (Z20)
Z20.9Contact with and (suspected) exposure to unspecified communicable diseaseContact w and (suspected) exposure to communicable diseases (Z20)
Z22.0Carrier of typhoidCarrier of infectious disease (Z22)
Z22.1Carrier of other intestinal infectious diseasesCarrier of infectious disease (Z22)
Z22.2Carrier of diphtheriaCarrier of infectious disease (Z22)
Z22.31Carrier of bacterial disease due to meningococciCarrier of infectious disease (Z22)
Z22.321Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureusCarrier of infectious disease (Z22)
Z22.322Carrier or suspected carrier of Methicillin resistant Staphylococcus aureusCarrier of infectious disease (Z22)
Z22.330Carrier of Group B streptococcusCarrier of infectious disease (Z22)
Z22.338Carrier of other streptococcusCarrier of infectious disease (Z22)
Z22.39Carrier of other specified bacterial diseasesCarrier of infectious disease (Z22)
Z22.4Carrier of infections with a predominantly sexual mode of transmissionCarrier of infectious disease (Z22)
Z22.6Carrier of human T-lymphotropic virus type-1 [HTLV-1] infectionCarrier of infectious disease (Z22)
Z22.8Carrier of other infectious diseasesCarrier of infectious disease (Z22)
Z22.9Carrier of infectious disease, unspecifiedCarrier of infectious disease (Z22)
Z23Encounter for immunizationEncounter for immunization (Z23)
Z28.01Immunization not carried out because of acute illness of patientImmunization not carried out and underimmunization status (Z28)
Z28.02Immunization not carried out because of chronic illness or condition of patientImmunization not carried out and underimmunization status (Z28)
Z28.03Immunization not carried out because of immune compromised state of patientImmunization not carried out and underimmunization status (Z28)
Z28.04Immunization not carried out because of patient allergy to vaccine or componentImmunization not carried out and underimmunization status (Z28)
Z28.09Immunization not carried out because of other contraindicationImmunization not carried out and underimmunization status (Z28)
Z28.1Immunization not carried out because of patient decision for reasons of belief or group pressureImmunization not carried out and underimmunization status (Z28)
Z28.20Immunization not carried out because of patient decision for unspecified reasonImmunization not carried out and underimmunization status (Z28)
Z28.21Immunization not carried out because of patient refusalImmunization not carried out and underimmunization status (Z28)
Z28.29Immunization not carried out because of patient decision for other reasonImmunization not carried out and underimmunization status (Z28)
Z28.3Underimmunization statusImmunization not carried out and underimmunization status (Z28)
Z28.81Immunization not carried out due to patient having had the diseaseImmunization not carried out and underimmunization status (Z28)
Z28.82Immunization not carried out because of caregiver refusalImmunization not carried out and underimmunization status (Z28)
Z28.89Immunization not carried out for other reasonImmunization not carried out and underimmunization status (Z28)
Z28.9Immunization not carried out for unspecified reasonImmunization not carried out and underimmunization status (Z28)
Z29.11Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)Encounter for other prophylactic measures (Z29)
Z29.12Encounter for prophylactic antiveninEncounter for other prophylactic measures (Z29)
Z29.13Encounter for prophylactic Rho(D) immune globulinEncounter for other prophylactic measures (Z29)
Z29.14Encounter for prophylactic rabies immune globinEncounter for other prophylactic measures (Z29)
Z29.3Encounter for prophylactic fluoride administrationEncounter for other prophylactic measures (Z29)
Z29.8Encounter for other specified prophylactic measuresEncounter for other prophylactic measures (Z29)
Z29.9Encounter for prophylactic measures, unspecifiedEncounter for other prophylactic measures (Z29)
Z30.011Encounter for initial prescription of contraceptive pillsEncounter for contraceptive management (Z30)
Z30.012Encounter for prescription of emergency contraceptionEncounter for contraceptive management (Z30)
Z30.013Encounter for initial prescription of injectable contraceptiveEncounter for contraceptive management (Z30)
Z30.014Encounter for initial prescription of intrauterine contraceptive deviceEncounter for contraceptive management (Z30)
Z30.015Encounter for initial prescription of vaginal ring hormonal contraceptiveEncounter for contraceptive management (Z30)
Z30.016Encounter for initial prescription of transdermal patch hormonal contraceptive deviceEncounter for contraceptive management (Z30)
Z30.017Encounter for initial prescription of implantable subdermal contraceptiveEncounter for contraceptive management (Z30)
Z30.018Encounter for initial prescription of other contraceptivesEncounter for contraceptive management (Z30)
Z30.019Encounter for initial prescription of contraceptives, unspecifiedEncounter for contraceptive management (Z30)
Z30.02Counseling and instruction in natural family planning to avoid pregnancyEncounter for contraceptive management (Z30)
Z30.09Encounter for other general counseling and advice on contraceptionEncounter for contraceptive management (Z30)
Z30.40Encounter for surveillance of contraceptives, unspecifiedEncounter for contraceptive management (Z30)
Z30.41Encounter for surveillance of contraceptive pillsEncounter for contraceptive management (Z30)
Z30.42Encounter for surveillance of injectable contraceptiveEncounter for contraceptive management (Z30)
Z30.430Encounter for insertion of intrauterine contraceptive deviceEncounter for contraceptive management (Z30)
Z30.431Encounter for routine checking of intrauterine contraceptive deviceEncounter for contraceptive management (Z30)
Z30.432Encounter for removal of intrauterine contraceptive deviceEncounter for contraceptive management (Z30)
Z30.433Encounter for removal and reinsertion of intrauterine contraceptive deviceEncounter for contraceptive management (Z30)
Z30.44Encounter for surveillance of vaginal ring hormonal contraceptive deviceEncounter for contraceptive management (Z30)
Z30.45Encounter for surveillance of transdermal patch hormonal contraceptive deviceEncounter for contraceptive management (Z30)
Z30.46Encounter for surveillance of implantable subdermal contraceptiveEncounter for contraceptive management (Z30)
Z30.49Encounter for surveillance of other contraceptivesEncounter for contraceptive management (Z30)
Z30.8Encounter for other contraceptive managementEncounter for contraceptive management (Z30)
Z30.9Encounter for contraceptive management, unspecifiedEncounter for contraceptive management (Z30)
Z31.41Encounter for fertility testingEncounter for procreative management (Z31)
Z31.42Aftercare following sterilization reversalEncounter for procreative management (Z31)
Z31.430Encounter of female for testing for genetic disease carrier status for procreative managementEncounter for procreative management (Z31)
Z31.438Encounter for other genetic testing of female for procreative managementEncounter for procreative management (Z31)
Z31.440Encounter of male for testing for genetic disease carrier status for procreative managementEncounter for procreative management (Z31)
Z31.441Encounter for testing of male partner of patient with recurrent pregnancy lossEncounter for procreative management (Z31)
Z31.448Encounter for other genetic testing of male for procreative managementEncounter for procreative management (Z31)
Z31.49Encounter for other procreative investigation and testingEncounter for procreative management (Z31)
Z31.5Encounter for procreative genetic counselingEncounter for procreative management (Z31)
Z31.61Procreative counseling and advice using natural family planningEncounter for procreative management (Z31)
Z31.62Encounter for fertility preservation counselingEncounter for procreative management (Z31)
Z31.69Encounter for other general counseling and advice on procreationEncounter for procreative management (Z31)
Z31.7Encounter for procreative management and counseling for gestational carrierEncounter for procreative management (Z31)
Z31.81Encounter for male factor infertility in female patientEncounter for procreative management (Z31)
Z31.82Encounter for Rh incompatibility statusEncounter for procreative management (Z31)
Z31.83Encounter for assisted reproductive fertility procedure cycleEncounter for procreative management (Z31)
Z31.84Encounter for fertility preservation procedureEncounter for procreative management (Z31)
Z31.89Encounter for other procreative managementEncounter for procreative management (Z31)
Z31.9Encounter for procreative management, unspecifiedEncounter for procreative management (Z31)
Z32.2Encounter for childbirth instructionEncntr for preg test and chldbrth and childcare instruction (Z32)
Z32.3Encounter for childcare instructionEncntr for preg test and chldbrth and childcare instruction (Z32)
Z33.1Pregnant state, incidentalPregnant state (Z33)
Z33.3Pregnant state, gestational carrierPregnant state (Z33)
Z34.00Encounter for supervision of normal first pregnancy, unspecified trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.01Encounter for supervision of normal first pregnancy, first trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.02Encounter for supervision of normal first pregnancy, second trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.03Encounter for supervision of normal first pregnancy, third trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.80Encounter for supervision of other normal pregnancy, unspecified trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.81Encounter for supervision of other normal pregnancy, first trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.82Encounter for supervision of other normal pregnancy, second trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.83Encounter for supervision of other normal pregnancy, third trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.90Encounter for supervision of normal pregnancy, unspecified, unspecified trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.91Encounter for supervision of normal pregnancy, unspecified, first trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.92Encounter for supervision of normal pregnancy, unspecified, second trimesterEncounter for supervision of normal pregnancy (Z34)
Z34.93Encounter for supervision of normal pregnancy, unspecified, third trimesterEncounter for supervision of normal pregnancy (Z34)
Z37.0Single live birthOutcome of delivery (Z37)
Z37.1Single stillbirthOutcome of delivery (Z37)
Z37.2Twins, both livebornOutcome of delivery (Z37)
Z37.3Twins, one liveborn and one stillbornOutcome of delivery (Z37)
Z37.4Twins, both stillbornOutcome of delivery (Z37)
Z37.50Multiple births, unspecified, all livebornOutcome of delivery (Z37)
Z37.51Triplets, all livebornOutcome of delivery (Z37)
Z37.52Quadruplets, all livebornOutcome of delivery (Z37)
Z37.53Quintuplets, all livebornOutcome of delivery (Z37)
Z37.54Sextuplets, all livebornOutcome of delivery (Z37)
Z37.59Other multiple births, all livebornOutcome of delivery (Z37)
Z37.60Multiple births, unspecified, some livebornOutcome of delivery (Z37)
Z37.61Triplets, some livebornOutcome of delivery (Z37)
Z37.62Quadruplets, some livebornOutcome of delivery (Z37)
Z37.63Quintuplets, some livebornOutcome of delivery (Z37)
Z37.64Sextuplets, some livebornOutcome of delivery (Z37)
Z37.69Other multiple births, some livebornOutcome of delivery (Z37)
Z37.7Other multiple births, all stillbornOutcome of delivery (Z37)
Z37.9Outcome of delivery, unspecifiedOutcome of delivery (Z37)
Z39.1Encounter for care and examination of lactating motherEncounter for maternal postpartum care and examination (Z39)
Z39.2Encounter for routine postpartum follow-upEncounter for maternal postpartum care and examination (Z39)
Z3A.00Weeks of gestation of pregnancy not specifiedWeeks of gestation (Z3A)
Z3A.01Less than 8 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.088 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.099 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1010 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1111 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1212 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1313 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1414 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1515 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1616 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1717 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1818 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.1919 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2020 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2121 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2222 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2323 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2424 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2525 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2626 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2727 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2828 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.2929 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3030 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3131 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3232 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3333 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3434 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3535 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3636 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3737 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3838 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.3939 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.4040 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.4141 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.4242 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z3A.49Greater than 42 weeks gestation of pregnancyWeeks of gestation (Z3A)
Z40.8Encounter for other prophylactic surgeryEncounter for prophylactic surgery (Z40)
Z40.9Encounter for prophylactic surgery, unspecifiedEncounter for prophylactic surgery (Z40)
Z41.3Encounter for ear piercingEncntr for proc for purposes oth than remedying health state (Z41)
Z41.9Encounter for procedure for purposes other than remedying health state, unspecifiedEncntr for proc for purposes oth than remedying health state (Z41)
Z43.9Encounter for attention to unspecified artificial openingEncounter for attention to artificial openings (Z43)
Z44.9Encounter for fitting and adjustment of unspecified external prosthetic deviceEncounter for fit/adjst of external prosthetic device (Z44)
Z45.82Encounter for adjustment or removal of myringotomy device (stent) (tube)Encounter for adjustment and management of implanted device (Z45)
Z45.89Encounter for adjustment and management of other implanted devicesEncounter for adjustment and management of implanted device (Z45)
Z45.9Encounter for adjustment and management of unspecified implanted deviceEncounter for adjustment and management of implanted device (Z45)
Z46.0Encounter for fitting and adjustment of spectacles and contact lensesEncounter for fitting and adjustment of other devices (Z46)
Z46.1Encounter for fitting and adjustment of hearing aidEncounter for fitting and adjustment of other devices (Z46)
Z46.4Encounter for fitting and adjustment of orthodontic deviceEncounter for fitting and adjustment of other devices (Z46)
Z46.51Encounter for fitting and adjustment of gastric lap bandEncounter for fitting and adjustment of other devices (Z46)
Z46.59Encounter for fitting and adjustment of other gastrointestinal appliance and deviceEncounter for fitting and adjustment of other devices (Z46)
Z46.6Encounter for fitting and adjustment of urinary deviceEncounter for fitting and adjustment of other devices (Z46)
Z46.81Encounter for fitting and adjustment of insulin pumpEncounter for fitting and adjustment of other devices (Z46)
Z46.89Encounter for fitting and adjustment of other specified devicesEncounter for fitting and adjustment of other devices (Z46)
Z46.9Encounter for fitting and adjustment of unspecified deviceEncounter for fitting and adjustment of other devices (Z46)
Z48.00Encounter for change or removal of nonsurgical wound dressingEncounter for other postprocedural aftercare (Z48)
Z48.01Encounter for change or removal of surgical wound dressingEncounter for other postprocedural aftercare (Z48)
Z48.02Encounter for removal of suturesEncounter for other postprocedural aftercare (Z48)
Z49.02Encounter for fitting and adjustment of peritoneal dialysis catheterEncounter for care involving renal dialysis (Z49)
Z49.31Encounter for adequacy testing for hemodialysisEncounter for care involving renal dialysis (Z49)
Z49.32Encounter for adequacy testing for peritoneal dialysisEncounter for care involving renal dialysis (Z49)
Z51.6Encounter for desensitization to allergensEncounter for other aftercare and medical care (Z51)
Z51.89Encounter for other specified aftercareEncounter for other aftercare and medical care (Z51)
Z52.000Unspecified donor, whole bloodDonors of organs and tissues (Z52)
Z52.001Unspecified donor, stem cellsDonors of organs and tissues (Z52)
Z52.008Unspecified donor, other bloodDonors of organs and tissues (Z52)
Z52.010Autologous donor, whole bloodDonors of organs and tissues (Z52)
Z52.011Autologous donor, stem cellsDonors of organs and tissues (Z52)
Z52.018Autologous donor, other bloodDonors of organs and tissues (Z52)
Z52.090Other blood donor, whole bloodDonors of organs and tissues (Z52)
Z52.091Other blood donor, stem cellsDonors of organs and tissues (Z52)
Z52.098Other blood donor, other bloodDonors of organs and tissues (Z52)
Z52.810Egg (Oocyte) donor under age 35, anonymous recipientDonors of organs and tissues (Z52)
Z52.811Egg (Oocyte) donor under age 35, designated recipientDonors of organs and tissues (Z52)
Z52.812Egg (Oocyte) donor age 35 and over, anonymous recipientDonors of organs and tissues (Z52)
Z52.813Egg (Oocyte) donor age 35 and over, designated recipientDonors of organs and tissues (Z52)
Z52.819Egg (Oocyte) donor, unspecifiedDonors of organs and tissues (Z52)
Z53.01Procedure and treatment not carried out due to patient smokingPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.09Procedure and treatment not carried out because of other contraindicationPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.1Procedure and treatment not carried out because of patient's decision for reasons of belief and group pressurePersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.20Procedure and treatment not carried out because of patient's decision for unspecified reasonsPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.21Procedure and treatment not carried out due to patient leaving prior to being seen by health care providerPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.29Procedure and treatment not carried out because of patient's decision for other reasonsPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.31Laparoscopic surgical procedure converted to open procedurePersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.32Thoracoscopic surgical procedure converted to open procedurePersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.33Arthroscopic surgical procedure converted to open procedurePersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.39Other specified procedure converted to open procedurePersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.8Procedure and treatment not carried out for other reasonsPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z53.9Procedure and treatment not carried out, unspecified reasonPersons encntr hlth serv for spec proc & trtmt, not crd out (Z53)
Z55.0Illiteracy and low-level literacyProblems related to education and literacy (Z55)
Z55.1Schooling unavailable and unattainableProblems related to education and literacy (Z55)
Z55.2Failed school examinationsProblems related to education and literacy (Z55)
Z55.3Underachievement in schoolProblems related to education and literacy (Z55)
Z55.4Educational maladjustment and discord with teachers and classmatesProblems related to education and literacy (Z55)
Z55.8Other problems related to education and literacyProblems related to education and literacy (Z55)
Z55.9Problems related to education and literacy, unspecifiedProblems related to education and literacy (Z55)
Z56.0Unemployment, unspecifiedProblems related to employment and unemployment (Z56)
Z56.1Change of jobProblems related to employment and unemployment (Z56)
Z56.2Threat of job lossProblems related to employment and unemployment (Z56)
Z56.3Stressful work scheduleProblems related to employment and unemployment (Z56)
Z56.4Discord with boss and workmatesProblems related to employment and unemployment (Z56)
Z56.5Uncongenial work environmentProblems related to employment and unemployment (Z56)
Z56.6Other physical and mental strain related to workProblems related to employment and unemployment (Z56)
Z56.81Sexual harassment on the jobProblems related to employment and unemployment (Z56)
Z56.82Military deployment statusProblems related to employment and unemployment (Z56)
Z56.89Other problems related to employmentProblems related to employment and unemployment (Z56)
Z56.9Unspecified problems related to employmentProblems related to employment and unemployment (Z56)
Z57.0Occupational exposure to noiseOccupational exposure to risk factors (Z57)
Z57.1Occupational exposure to radiationOccupational exposure to risk factors (Z57)
Z57.2Occupational exposure to dustOccupational exposure to risk factors (Z57)
Z57.31Occupational exposure to environmental tobacco smokeOccupational exposure to risk factors (Z57)
Z57.39Occupational exposure to other air contaminantsOccupational exposure to risk factors (Z57)
Z57.4Occupational exposure to toxic agents in agricultureOccupational exposure to risk factors (Z57)
Z57.5Occupational exposure to toxic agents in other industriesOccupational exposure to risk factors (Z57)
Z57.6Occupational exposure to extreme temperatureOccupational exposure to risk factors (Z57)
Z57.7Occupational exposure to vibrationOccupational exposure to risk factors (Z57)
Z57.8Occupational exposure to other risk factorsOccupational exposure to risk factors (Z57)
Z57.9Occupational exposure to unspecified risk factorOccupational exposure to risk factors (Z57)
Z59.0HomelessnessProblems related to housing and economic circumstances (Z59)
Z59.1Inadequate housingProblems related to housing and economic circumstances (Z59)
Z59.2Discord with neighbors, lodgers and landlordProblems related to housing and economic circumstances (Z59)
Z59.3Problems related to living in residential institutionProblems related to housing and economic circumstances (Z59)
Z59.4Lack of adequate food and safe drinking waterProblems related to housing and economic circumstances (Z59)
Z59.5Extreme povertyProblems related to housing and economic circumstances (Z59)
Z59.6Low incomeProblems related to housing and economic circumstances (Z59)
Z59.7Insufficient social insurance and welfare supportProblems related to housing and economic circumstances (Z59)
Z59.8Other problems related to housing and economic circumstancesProblems related to housing and economic circumstances (Z59)
Z59.9Problem related to housing and economic circumstances, unspecifiedProblems related to housing and economic circumstances (Z59)
Z60.0Problems of adjustment to life-cycle transitionsProblems related to social environment (Z60)
Z60.2Problems related to living aloneProblems related to social environment (Z60)
Z60.3Acculturation difficultyProblems related to social environment (Z60)
Z60.4Social exclusion and rejectionProblems related to social environment (Z60)
Z60.5Target of (perceived) adverse discrimination and persecutionProblems related to social environment (Z60)
Z60.8Other problems related to social environmentProblems related to social environment (Z60)
Z60.9Problem related to social environment, unspecifiedProblems related to social environment (Z60)
Z62.0Inadequate parental supervision and controlProblems related to upbringing (Z62)
Z62.1Parental overprotectionProblems related to upbringing (Z62)
Z62.21Child in welfare custodyProblems related to upbringing (Z62)
Z62.22Institutional upbringingProblems related to upbringing (Z62)
Z62.29Other upbringing away from parentsProblems related to upbringing (Z62)
Z62.3Hostility towards and scapegoating of childProblems related to upbringing (Z62)
Z62.6Inappropriate (excessive) parental pressureProblems related to upbringing (Z62)
Z62.810Personal history of physical and sexual abuse in childhoodProblems related to upbringing (Z62)
Z62.811Personal history of psychological abuse in childhoodProblems related to upbringing (Z62)
Z62.812Personal history of neglect in childhoodProblems related to upbringing (Z62)
Z62.819Personal history of unspecified abuse in childhoodProblems related to upbringing (Z62)
Z62.820Parent-biological child conflictProblems related to upbringing (Z62)
Z62.821Parent-adopted child conflictProblems related to upbringing (Z62)
Z62.822Parent-foster child conflictProblems related to upbringing (Z62)
Z62.890Parent-child estrangement NECProblems related to upbringing (Z62)
Z62.891Sibling rivalryProblems related to upbringing (Z62)
Z62.898Other specified problems related to upbringingProblems related to upbringing (Z62)
Z62.9Problem related to upbringing, unspecifiedProblems related to upbringing (Z62)
Z63.0Problems in relationship with spouse or partnerOth prob rel to prim support group, inc family circumstances (Z63)
Z63.1Problems in relationship with in-lawsOth prob rel to prim support group, inc family circumstances (Z63)
Z63.31Absence of family member due to military deploymentOth prob rel to prim support group, inc family circumstances (Z63)
Z63.32Other absence of family memberOth prob rel to prim support group, inc family circumstances (Z63)
Z63.4Disappearance and death of family memberOth prob rel to prim support group, inc family circumstances (Z63)
Z63.5Disruption of family by separation and divorceOth prob rel to prim support group, inc family circumstances (Z63)
Z63.6Dependent relative needing care at homeOth prob rel to prim support group, inc family circumstances (Z63)
Z63.71Stress on family due to return of family member from military deploymentOth prob rel to prim support group, inc family circumstances (Z63)
Z63.72Alcoholism and drug addiction in familyOth prob rel to prim support group, inc family circumstances (Z63)
Z63.79Other stressful life events affecting family and householdOth prob rel to prim support group, inc family circumstances (Z63)
Z63.8Other specified problems related to primary support groupOth prob rel to prim support group, inc family circumstances (Z63)
Z63.9Problem related to primary support group, unspecifiedOth prob rel to prim support group, inc family circumstances (Z63)
Z64.0Problems related to unwanted pregnancyProblems related to certain psychosocial circumstances (Z64)
Z64.1Problems related to multiparityProblems related to certain psychosocial circumstances (Z64)
Z64.4Discord with counselorsProblems related to certain psychosocial circumstances (Z64)
Z65.0Conviction in civil and criminal proceedings without imprisonmentProblems related to other psychosocial circumstances (Z65)
Z65.1Imprisonment and other incarcerationProblems related to other psychosocial circumstances (Z65)
Z65.2Problems related to release from prisonProblems related to other psychosocial circumstances (Z65)
Z65.3Problems related to other legal circumstancesProblems related to other psychosocial circumstances (Z65)
Z65.4Victim of crime and terrorismProblems related to other psychosocial circumstances (Z65)
Z65.5Exposure to disaster, war and other hostilitiesProblems related to other psychosocial circumstances (Z65)
Z65.8Other specified problems related to psychosocial circumstancesProblems related to other psychosocial circumstances (Z65)
Z65.9Problem related to unspecified psychosocial circumstancesProblems related to other psychosocial circumstances (Z65)
Z66Do not resuscitateDo not resuscitate (Z66)
Z67.10Type A blood, Rh positiveBlood type (Z67)
Z67.11Type A blood, Rh negativeBlood type (Z67)
Z67.20Type B blood, Rh positiveBlood type (Z67)
Z67.21Type B blood, Rh negativeBlood type (Z67)
Z67.30Type AB blood, Rh positiveBlood type (Z67)
Z67.31Type AB blood, Rh negativeBlood type (Z67)
Z67.40Type O blood, Rh positiveBlood type (Z67)
Z67.41Type O blood, Rh negativeBlood type (Z67)
Z67.90Unspecified blood type, Rh positiveBlood type (Z67)
Z67.91Unspecified blood type, Rh negativeBlood type (Z67)
Z68.1Body mass index (BMI) 19.9 or less, adultBody mass index [BMI] (Z68)
Z68.20Body mass index (BMI) 20.0-20.9, adultBody mass index [BMI] (Z68)
Z68.21Body mass index (BMI) 21.0-21.9, adultBody mass index [BMI] (Z68)
Z68.22Body mass index (BMI) 22.0-22.9, adultBody mass index [BMI] (Z68)
Z68.23Body mass index (BMI) 23.0-23.9, adultBody mass index [BMI] (Z68)
Z68.24Body mass index (BMI) 24.0-24.9, adultBody mass index [BMI] (Z68)
Z68.25Body mass index (BMI) 25.0-25.9, adultBody mass index [BMI] (Z68)
Z68.26Body mass index (BMI) 26.0-26.9, adultBody mass index [BMI] (Z68)
Z68.27Body mass index (BMI) 27.0-27.9, adultBody mass index [BMI] (Z68)
Z68.28Body mass index (BMI) 28.0-28.9, adultBody mass index [BMI] (Z68)
Z68.29Body mass index (BMI) 29.0-29.9, adultBody mass index [BMI] (Z68)
Z68.30Body mass index (BMI) 30.0-30.9, adultBody mass index [BMI] (Z68)
Z68.31Body mass index (BMI) 31.0-31.9, adultBody mass index [BMI] (Z68)
Z68.32Body mass index (BMI) 32.0-32.9, adultBody mass index [BMI] (Z68)
Z68.33Body mass index (BMI) 33.0-33.9, adultBody mass index [BMI] (Z68)
Z68.34Body mass index (BMI) 34.0-34.9, adultBody mass index [BMI] (Z68)
Z68.35Body mass index (BMI) 35.0-35.9, adultBody mass index [BMI] (Z68)
Z68.36Body mass index (BMI) 36.0-36.9, adultBody mass index [BMI] (Z68)
Z68.37Body mass index (BMI) 37.0-37.9, adultBody mass index [BMI] (Z68)
Z68.38Body mass index (BMI) 38.0-38.9, adultBody mass index [BMI] (Z68)
Z68.39Body mass index (BMI) 39.0-39.9, adultBody mass index [BMI] (Z68)
Z68.41Body mass index (BMI) 40.0-44.9, adultBody mass index [BMI] (Z68)
Z68.42Body mass index (BMI) 45.0-49.9, adultBody mass index [BMI] (Z68)
Z68.43Body mass index (BMI) 50-59.9 , adultBody mass index [BMI] (Z68)
Z68.44Body mass index (BMI) 60.0-69.9, adultBody mass index [BMI] (Z68)
Z68.45Body mass index (BMI) 70 or greater, adultBody mass index [BMI] (Z68)
Z68.51Body mass index (BMI) pediatric, less than 5th percentile for ageBody mass index [BMI] (Z68)
Z68.52Body mass index (BMI) pediatric, 5th percentile to less than 85th percentile for ageBody mass index [BMI] (Z68)
Z68.53Body mass index (BMI) pediatric, 85th percentile to less than 95th percentile for ageBody mass index [BMI] (Z68)
Z68.54Body mass index (BMI) pediatric, greater than or equal to 95th percentile for ageBody mass index [BMI] (Z68)
Z69.011Encounter for mental health services for perpetrator of parental child abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z69.021Encounter for mental health services for perpetrator of non-parental child abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z69.11Encounter for mental health services for victim of spousal or partner abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z69.12Encounter for mental health services for perpetrator of spousal or partner abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z69.81Encounter for mental health services for victim of other abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z69.82Encounter for mental health services for perpetrator of other abuseEncntr for mental health serv for victim and perp of abuse (Z69)
Z70.0Counseling related to sexual attitudeCounseling related to sexual attitude, behavior and orientn (Z70)
Z70.1Counseling related to patient's sexual behavior and orientationCounseling related to sexual attitude, behavior and orientn (Z70)
Z70.2Counseling related to sexual behavior and orientation of third partyCounseling related to sexual attitude, behavior and orientn (Z70)
Z70.3Counseling related to combined concerns regarding sexual attitude, behavior and orientationCounseling related to sexual attitude, behavior and orientn (Z70)
Z70.8Other sex counselingCounseling related to sexual attitude, behavior and orientn (Z70)
Z70.9Sex counseling, unspecifiedCounseling related to sexual attitude, behavior and orientn (Z70)
Z71.0Person encountering health services to consult on behalf of another personPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.1Person with feared health complaint in whom no diagnosis is madePersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.2Person consulting for explanation of examination or test findingsPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.3Dietary counseling and surveillancePersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.41Alcohol abuse counseling and surveillance of alcoholicPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.42Counseling for family member of alcoholicPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.51Drug abuse counseling and surveillance of drug abuserPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.52Counseling for family member of drug abuserPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.6Tobacco abuse counselingPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.7Human immunodeficiency virus [HIV] counselingPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.81Spiritual or religious counselingPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.82Exercise counselingPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.89Other specified counselingPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z71.9Counseling, unspecifiedPersons encntr health serv for oth cnsl and med advice, NEC (Z71)
Z72.0Tobacco useProblems related to lifestyle (Z72)
Z72.3Lack of physical exerciseProblems related to lifestyle (Z72)
Z72.4Inappropriate diet and eating habitsProblems related to lifestyle (Z72)
Z72.51High risk heterosexual behaviorProblems related to lifestyle (Z72)
Z72.52High risk homosexual behaviorProblems related to lifestyle (Z72)
Z72.53High risk bisexual behaviorProblems related to lifestyle (Z72)
Z72.6Gambling and bettingProblems related to lifestyle (Z72)
Z72.821Inadequate sleep hygieneProblems related to lifestyle (Z72)
Z72.89Other problems related to lifestyleProblems related to lifestyle (Z72)
Z72.9Problem related to lifestyle, unspecifiedProblems related to lifestyle (Z72)
Z73.0Burn-outProblems related to life management difficulty (Z73)
Z73.1Type A behavior patternProblems related to life management difficulty (Z73)
Z73.2Lack of relaxation and leisureProblems related to life management difficulty (Z73)
Z73.3Stress, not elsewhere classifiedProblems related to life management difficulty (Z73)
Z73.4Inadequate social skills, not elsewhere classifiedProblems related to life management difficulty (Z73)
Z73.5Social role conflict, not elsewhere classifiedProblems related to life management difficulty (Z73)
Z73.6Limitation of activities due to disabilityProblems related to life management difficulty (Z73)
Z73.810Behavioral insomnia of childhood, sleep-onset association typeProblems related to life management difficulty (Z73)
Z73.811Behavioral insomnia of childhood, limit setting typeProblems related to life management difficulty (Z73)
Z73.812Behavioral insomnia of childhood, combined typeProblems related to life management difficulty (Z73)
Z73.819Behavioral insomnia of childhood, unspecified typeProblems related to life management difficulty (Z73)
Z73.82Dual sensory impairmentProblems related to life management difficulty (Z73)
Z73.89Other problems related to life management difficultyProblems related to life management difficulty (Z73)
Z73.9Problem related to life management difficulty, unspecifiedProblems related to life management difficulty (Z73)
Z74.01Bed confinement statusProblems related to care provider dependency (Z74)
Z74.09Other reduced mobilityProblems related to care provider dependency (Z74)
Z74.1Need for assistance with personal careProblems related to care provider dependency (Z74)
Z74.2Need for assistance at home and no other household member able to render careProblems related to care provider dependency (Z74)
Z74.3Need for continuous supervisionProblems related to care provider dependency (Z74)
Z74.8Other problems related to care provider dependencyProblems related to care provider dependency (Z74)
Z74.9Problem related to care provider dependency, unspecifiedProblems related to care provider dependency (Z74)
Z75.0Medical services not available in homeProblems related to medical facilities and other health care (Z75)
Z75.1Person awaiting admission to adequate facility elsewhereProblems related to medical facilities and other health care (Z75)
Z75.2Other waiting period for investigation and treatmentProblems related to medical facilities and other health care (Z75)
Z75.3Unavailability and inaccessibility of health-care facilitiesProblems related to medical facilities and other health care (Z75)
Z75.4Unavailability and inaccessibility of other helping agenciesProblems related to medical facilities and other health care (Z75)
Z75.5Holiday relief careProblems related to medical facilities and other health care (Z75)
Z75.8Other problems related to medical facilities and other health careProblems related to medical facilities and other health care (Z75)
Z75.9Unspecified problem related to medical facilities and other health careProblems related to medical facilities and other health care (Z75)
Z76.0Encounter for issue of repeat prescriptionPersons encountering health services in other circumstances (Z76)
Z76.2Encounter for health supervision and care of other healthy infant and childPersons encountering health services in other circumstances (Z76)
Z76.81Expectant parent(s) prebirth pediatrician visitPersons encountering health services in other circumstances (Z76)
Z76.82Awaiting organ transplant statusPersons encountering health services in other circumstances (Z76)
Z76.89Persons encountering health services in other specified circumstancesPersons encountering health services in other circumstances (Z76)
Z77.010Contact with and (suspected) exposure to arsenicOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.011Contact with and (suspected) exposure to leadOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.012Contact with and (suspected) exposure to uraniumOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.018Contact with and (suspected) exposure to other hazardous metalsOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.020Contact with and (suspected) exposure to aromatic aminesOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.021Contact with and (suspected) exposure to benzeneOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.028Contact with and (suspected) exposure to other hazardous aromatic compoundsOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.090Contact with and (suspected) exposure to asbestosOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.098Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicalsOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.110Contact with and (suspected) exposure to air pollutionOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.111Contact with and (suspected) exposure to water pollutionOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.112Contact with and (suspected) exposure to soil pollutionOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.118Contact with and (suspected) exposure to other environmental pollutionOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.120Contact with and (suspected) exposure to mold (toxic)Oth contact w and (suspected) exposures hazardous to health (Z77)
Z77.121Contact with and (suspected) exposure to harmful algae and algae toxinsOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.122Contact with and (suspected) exposure to noiseOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.123Contact with and (suspected) exposure to radon and other naturally occuring radiationOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.128Contact with and (suspected) exposure to other hazards in the physical environmentOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.21Contact with and (suspected) exposure to potentially hazardous body fluidsOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.22Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)Oth contact w and (suspected) exposures hazardous to health (Z77)
Z77.29Contact with and (suspected ) exposure to other hazardous substancesOth contact w and (suspected) exposures hazardous to health (Z77)
Z77.9Other contact with and (suspected) exposures hazardous to healthOth contact w and (suspected) exposures hazardous to health (Z77)
Z78.0Asymptomatic menopausal stateOther specified health status (Z78)
Z78.1Physical restraint statusOther specified health status (Z78)
Z78.9Other specified health statusOther specified health status (Z78)
Z79.02Long term (current) use of antithrombotics/antiplateletsLong term (current) drug therapy (Z79)
Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)Long term (current) drug therapy (Z79)
Z79.2Long term (current) use of antibioticsLong term (current) drug therapy (Z79)
Z79.51Long term (current) use of inhaled steroidsLong term (current) drug therapy (Z79)
Z79.52Long term (current) use of systemic steroidsLong term (current) drug therapy (Z79)
Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)Long term (current) drug therapy (Z79)
Z79.811Long term (current) use of aromatase inhibitorsLong term (current) drug therapy (Z79)
Z79.818Long term (current) use of other agents affecting estrogen receptors and estrogen levelsLong term (current) drug therapy (Z79)
Z79.83Long term (current) use of bisphosphonatesLong term (current) drug therapy (Z79)
Z79.84Long term (current) use of oral hypoglycemic drugsLong term (current) drug therapy (Z79)
Z79.890Hormone replacement therapyLong term (current) drug therapy (Z79)
Z80.0Family history of malignant neoplasm of digestive organsFamily history of primary malignant neoplasm (Z80)
Z80.1Family history of malignant neoplasm of trachea, bronchus and lungFamily history of primary malignant neoplasm (Z80)
Z80.2Family history of malignant neoplasm of other respiratory and intrathoracic organsFamily history of primary malignant neoplasm (Z80)
Z80.3Family history of malignant neoplasm of breastFamily history of primary malignant neoplasm (Z80)
Z80.41Family history of malignant neoplasm of ovaryFamily history of primary malignant neoplasm (Z80)
Z80.42Family history of malignant neoplasm of prostateFamily history of primary malignant neoplasm (Z80)
Z80.43Family history of malignant neoplasm of testisFamily history of primary malignant neoplasm (Z80)
Z80.49Family history of malignant neoplasm of other genital organsFamily history of primary malignant neoplasm (Z80)
Z80.51Family history of malignant neoplasm of kidneyFamily history of primary malignant neoplasm (Z80)
Z80.52Family history of malignant neoplasm of bladderFamily history of primary malignant neoplasm (Z80)
Z80.59Family history of malignant neoplasm of other urinary tract organFamily history of primary malignant neoplasm (Z80)
Z80.6Family history of leukemiaFamily history of primary malignant neoplasm (Z80)
Z80.7Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissuesFamily history of primary malignant neoplasm (Z80)
Z80.8Family history of malignant neoplasm of other organs or systemsFamily history of primary malignant neoplasm (Z80)
Z80.9Family history of malignant neoplasm, unspecifiedFamily history of primary malignant neoplasm (Z80)
Z81.0Family history of intellectual disabilitiesFamily history of mental and behavioral disorders (Z81)
Z81.1Family history of alcohol abuse and dependenceFamily history of mental and behavioral disorders (Z81)
Z81.2Family history of tobacco abuse and dependenceFamily history of mental and behavioral disorders (Z81)
Z81.3Family history of other psychoactive substance abuse and dependenceFamily history of mental and behavioral disorders (Z81)
Z81.4Family history of other substance abuse and dependenceFamily history of mental and behavioral disorders (Z81)
Z81.8Family history of other mental and behavioral disordersFamily history of mental and behavioral disorders (Z81)
Z82.0Family history of epilepsy and other diseases of the nervous systemFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.1Family history of blindness and visual lossFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.2Family history of deafness and hearing lossFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.3Family history of strokeFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.41Family history of sudden cardiac deathFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.49Family history of ischemic heart disease and other diseases of the circulatory systemFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.5Family history of asthma and other chronic lower respiratory diseasesFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.61Family history of arthritisFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.62Family history of osteoporosisFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.69Family history of other diseases of the musculoskeletal system and connective tissueFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.71Family history of polycystic kidneyFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.79Family history of other congenital malformations, deformations and chromosomal abnormalitiesFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z82.8Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classifiedFam hx of certain disabil & chr dis (leading to disablement) (Z82)
Z83.0Family history of human immunodeficiency virus [HIV] diseaseFamily history of other specific disorders (Z83)
Z83.1Family history of other infectious and parasitic diseasesFamily history of other specific disorders (Z83)
Z83.2Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismFamily history of other specific disorders (Z83)
Z83.3Family history of diabetes mellitusFamily history of other specific disorders (Z83)
Z83.41Family history of multiple endocrine neoplasia [MEN] syndromeFamily history of other specific disorders (Z83)
Z83.42Family history of familial hypercholesterolemiaFamily history of other specific disorders (Z83)
Z83.49Family history of other endocrine, nutritional and metabolic diseasesFamily history of other specific disorders (Z83)
Z83.511Family history of glaucomaFamily history of other specific disorders (Z83)
Z83.518Family history of other specified eye disorderFamily history of other specific disorders (Z83)
Z83.52Family history of ear disordersFamily history of other specific disorders (Z83)
Z83.6Family history of other diseases of the respiratory systemFamily history of other specific disorders (Z83)
Z83.71Family history of colonic polypsFamily history of other specific disorders (Z83)
Z83.79Family history of other diseases of the digestive systemFamily history of other specific disorders (Z83)
Z84.0Family history of diseases of the skin and subcutaneous tissueFamily history of other conditions (Z84)
Z84.1Family history of disorders of kidney and ureterFamily history of other conditions (Z84)
Z84.2Family history of other diseases of the genitourinary systemFamily history of other conditions (Z84)
Z84.3Family history of consanguinityFamily history of other conditions (Z84)
Z84.81Family history of carrier of genetic diseaseFamily history of other conditions (Z84)
Z84.82Family history of sudden infant death syndromeFamily history of other conditions (Z84)
Z84.89Family history of other specified conditionsFamily history of other conditions (Z84)
Z85.00Personal history of malignant neoplasm of unspecified digestive organPersonal history of malignant neoplasm (Z85)
Z85.01Personal history of malignant neoplasm of esophagusPersonal history of malignant neoplasm (Z85)
Z85.020Personal history of malignant carcinoid tumor of stomachPersonal history of malignant neoplasm (Z85)
Z85.028Personal history of other malignant neoplasm of stomachPersonal history of malignant neoplasm (Z85)
Z85.030Personal history of malignant carcinoid tumor of large intestinePersonal history of malignant neoplasm (Z85)
Z85.038Personal history of other malignant neoplasm of large intestinePersonal history of malignant neoplasm (Z85)
Z85.040Personal history of malignant carcinoid tumor of rectumPersonal history of malignant neoplasm (Z85)
Z85.048Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anusPersonal history of malignant neoplasm (Z85)
Z85.05Personal history of malignant neoplasm of liverPersonal history of malignant neoplasm (Z85)
Z85.060Personal history of malignant carcinoid tumor of small intestinePersonal history of malignant neoplasm (Z85)
Z85.068Personal history of other malignant neoplasm of small intestinePersonal history of malignant neoplasm (Z85)
Z85.07Personal history of malignant neoplasm of pancreasPersonal history of malignant neoplasm (Z85)
Z85.09Personal history of malignant neoplasm of other digestive organsPersonal history of malignant neoplasm (Z85)
Z85.110Personal history of malignant carcinoid tumor of bronchus and lungPersonal history of malignant neoplasm (Z85)
Z85.118Personal history of other malignant neoplasm of bronchus and lungPersonal history of malignant neoplasm (Z85)
Z85.12Personal history of malignant neoplasm of tracheaPersonal history of malignant neoplasm (Z85)
Z85.20Personal history of malignant neoplasm of unspecified respiratory organPersonal history of malignant neoplasm (Z85)
Z85.21Personal history of malignant neoplasm of larynxPersonal history of malignant neoplasm (Z85)
Z85.22Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinusesPersonal history of malignant neoplasm (Z85)
Z85.230Personal history of malignant carcinoid tumor of thymusPersonal history of malignant neoplasm (Z85)
Z85.238Personal history of other malignant neoplasm of thymusPersonal history of malignant neoplasm (Z85)
Z85.29Personal history of malignant neoplasm of other respiratory and intrathoracic organsPersonal history of malignant neoplasm (Z85)
Z85.3Personal history of malignant neoplasm of breastPersonal history of malignant neoplasm (Z85)
Z85.40Personal history of malignant neoplasm of unspecified female genital organPersonal history of malignant neoplasm (Z85)
Z85.41Personal history of malignant neoplasm of cervix uteriPersonal history of malignant neoplasm (Z85)
Z85.42Personal history of malignant neoplasm of other parts of uterusPersonal history of malignant neoplasm (Z85)
Z85.43Personal history of malignant neoplasm of ovaryPersonal history of malignant neoplasm (Z85)
Z85.44Personal history of malignant neoplasm of other female genital organsPersonal history of malignant neoplasm (Z85)
Z85.45Personal history of malignant neoplasm of unspecified male genital organPersonal history of malignant neoplasm (Z85)
Z85.46Personal history of malignant neoplasm of prostatePersonal history of malignant neoplasm (Z85)
Z85.47Personal history of malignant neoplasm of testisPersonal history of malignant neoplasm (Z85)
Z85.48Personal history of malignant neoplasm of epididymisPersonal history of malignant neoplasm (Z85)
Z85.49Personal history of malignant neoplasm of other male genital organsPersonal history of malignant neoplasm (Z85)
Z85.50Personal history of malignant neoplasm of unspecified urinary tract organPersonal history of malignant neoplasm (Z85)
Z85.51Personal history of malignant neoplasm of bladderPersonal history of malignant neoplasm (Z85)
Z85.520Personal history of malignant carcinoid tumor of kidneyPersonal history of malignant neoplasm (Z85)
Z85.528Personal history of other malignant neoplasm of kidneyPersonal history of malignant neoplasm (Z85)
Z85.53Personal history of malignant neoplasm of renal pelvisPersonal history of malignant neoplasm (Z85)
Z85.54Personal history of malignant neoplasm of ureterPersonal history of malignant neoplasm (Z85)
Z85.59Personal history of malignant neoplasm of other urinary tract organPersonal history of malignant neoplasm (Z85)
Z85.6Personal history of leukemiaPersonal history of malignant neoplasm (Z85)
Z85.71Personal history of Hodgkin lymphomaPersonal history of malignant neoplasm (Z85)
Z85.72Personal history of non-Hodgkin lymphomasPersonal history of malignant neoplasm (Z85)
Z85.79Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissuesPersonal history of malignant neoplasm (Z85)
Z85.810Personal history of malignant neoplasm of tonguePersonal history of malignant neoplasm (Z85)
Z85.818Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynxPersonal history of malignant neoplasm (Z85)
Z85.819Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynxPersonal history of malignant neoplasm (Z85)
Z85.820Personal history of malignant melanoma of skinPersonal history of malignant neoplasm (Z85)
Z85.821Personal history of Merkel cell carcinomaPersonal history of malignant neoplasm (Z85)
Z85.828Personal history of other malignant neoplasm of skinPersonal history of malignant neoplasm (Z85)
Z85.830Personal history of malignant neoplasm of bonePersonal history of malignant neoplasm (Z85)
Z85.831Personal history of malignant neoplasm of soft tissuePersonal history of malignant neoplasm (Z85)
Z85.840Personal history of malignant neoplasm of eyePersonal history of malignant neoplasm (Z85)
Z85.841Personal history of malignant neoplasm of brainPersonal history of malignant neoplasm (Z85)
Z85.848Personal history of malignant neoplasm of other parts of nervous tissuePersonal history of malignant neoplasm (Z85)
Z85.850Personal history of malignant neoplasm of thyroidPersonal history of malignant neoplasm (Z85)
Z85.858Personal history of malignant neoplasm of other endocrine glandsPersonal history of malignant neoplasm (Z85)
Z85.89Personal history of malignant neoplasm of other organs and systemsPersonal history of malignant neoplasm (Z85)
Z85.9Personal history of malignant neoplasm, unspecifiedPersonal history of malignant neoplasm (Z85)
Z86.000Personal history of in-situ neoplasm of breastPersonal history of certain other diseases (Z86)
Z86.001Personal history of in-situ neoplasm of cervix uteriPersonal history of certain other diseases (Z86)
Z86.008Personal history of in-situ neoplasm of other sitePersonal history of certain other diseases (Z86)
Z86.010Personal history of colonic polypsPersonal history of certain other diseases (Z86)
Z86.011Personal history of benign neoplasm of the brainPersonal history of certain other diseases (Z86)
Z86.012Personal history of benign carcinoid tumorPersonal history of certain other diseases (Z86)
Z86.018Personal history of other benign neoplasmPersonal history of certain other diseases (Z86)
Z86.03Personal history of neoplasm of uncertain behaviorPersonal history of certain other diseases (Z86)
Z86.11Personal history of tuberculosisPersonal history of certain other diseases (Z86)
Z86.12Personal history of poliomyelitisPersonal history of certain other diseases (Z86)
Z86.13Personal history of malariaPersonal history of certain other diseases (Z86)
Z86.14Personal history of Methicillin resistant Staphylococcus aureus infectionPersonal history of certain other diseases (Z86)
Z86.19Personal history of other infectious and parasitic diseasesPersonal history of certain other diseases (Z86)
Z86.2Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanismPersonal history of certain other diseases (Z86)
Z86.31Personal history of diabetic foot ulcerPersonal history of certain other diseases (Z86)
Z86.32Personal history of gestational diabetesPersonal history of certain other diseases (Z86)
Z86.39Personal history of other endocrine, nutritional and metabolic diseasePersonal history of certain other diseases (Z86)
Z86.51Personal history of combat and operational stress reactionPersonal history of certain other diseases (Z86)
Z86.59Personal history of other mental and behavioral disordersPersonal history of certain other diseases (Z86)
Z86.61Personal history of infections of the central nervous systemPersonal history of certain other diseases (Z86)
Z86.69Personal history of other diseases of the nervous system and sense organsPersonal history of certain other diseases (Z86)
Z86.711Personal history of pulmonary embolismPersonal history of certain other diseases (Z86)
Z86.718Personal history of other venous thrombosis and embolismPersonal history of certain other diseases (Z86)
Z86.72Personal history of thrombophlebitisPersonal history of certain other diseases (Z86)
Z86.73Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficitsPersonal history of certain other diseases (Z86)
Z86.74Personal history of sudden cardiac arrestPersonal history of certain other diseases (Z86)
Z86.79Personal history of other diseases of the circulatory systemPersonal history of certain other diseases (Z86)
Z87.01Personal history of pneumonia (recurrent)Personal history of other diseases and conditions (Z87)
Z87.09Personal history of other diseases of the respiratory systemPersonal history of other diseases and conditions (Z87)
Z87.11Personal history of peptic ulcer diseasePersonal history of other diseases and conditions (Z87)
Z87.19Personal history of other diseases of the digestive systemPersonal history of other diseases and conditions (Z87)
Z87.2Personal history of diseases of the skin and subcutaneous tissuePersonal history of other diseases and conditions (Z87)
Z87.310Personal history of (healed) osteoporosis fracturePersonal history of other diseases and conditions (Z87)
Z87.311Personal history of (healed) other pathological fracturePersonal history of other diseases and conditions (Z87)
Z87.312Personal history of (healed) stress fracturePersonal history of other diseases and conditions (Z87)
Z87.39Personal history of other diseases of the musculoskeletal system and connective tissuePersonal history of other diseases and conditions (Z87)
Z87.410Personal history of cervical dysplasiaPersonal history of other diseases and conditions (Z87)
Z87.411Personal history of vaginal dysplasiaPersonal history of other diseases and conditions (Z87)
Z87.412Personal history of vulvar dysplasiaPersonal history of other diseases and conditions (Z87)
Z87.42Personal history of other diseases of the female genital tractPersonal history of other diseases and conditions (Z87)
Z87.430Personal history of prostatic dysplasiaPersonal history of other diseases and conditions (Z87)
Z87.438Personal history of other diseases of male genital organsPersonal history of other diseases and conditions (Z87)
Z87.440Personal history of urinary (tract) infectionsPersonal history of other diseases and conditions (Z87)
Z87.441Personal history of nephrotic syndromePersonal history of other diseases and conditions (Z87)
Z87.442Personal history of urinary calculiPersonal history of other diseases and conditions (Z87)
Z87.448Personal history of other diseases of urinary systemPersonal history of other diseases and conditions (Z87)
Z87.51Personal history of pre-term laborPersonal history of other diseases and conditions (Z87)
Z87.59Personal history of other complications of pregnancy, childbirth and the puerperiumPersonal history of other diseases and conditions (Z87)
Z87.710Personal history of (corrected) hypospadiasPersonal history of other diseases and conditions (Z87)
Z87.718Personal history of other specified (corrected) congenital malformations of genitourinary systemPersonal history of other diseases and conditions (Z87)
Z87.720Personal history of (corrected) congenital malformations of eyePersonal history of other diseases and conditions (Z87)
Z87.721Personal history of (corrected) congenital malformations of earPersonal history of other diseases and conditions (Z87)
Z87.728Personal history of other specified (corrected) congenital malformations of nervous system and sense organsPersonal history of other diseases and conditions (Z87)
Z87.730Personal history of (corrected) cleft lip and palatePersonal history of other diseases and conditions (Z87)
Z87.738Personal history of other specified (corrected) congenital malformations of digestive systemPersonal history of other diseases and conditions (Z87)
Z87.74Personal history of (corrected) congenital malformations of heart and circulatory systemPersonal history of other diseases and conditions (Z87)
Z87.75Personal history of (corrected) congenital malformations of respiratory systemPersonal history of other diseases and conditions (Z87)
Z87.76Personal history of (corrected) congenital malformations of integument, limbs and musculoskeletal systemPersonal history of other diseases and conditions (Z87)
Z87.790Personal history of (corrected) congenital malformations of face and neckPersonal history of other diseases and conditions (Z87)
Z87.798Personal history of other (corrected) congenital malformationsPersonal history of other diseases and conditions (Z87)
Z87.81Personal history of (healed) traumatic fracturePersonal history of other diseases and conditions (Z87)
Z87.820Personal history of traumatic brain injuryPersonal history of other diseases and conditions (Z87)
Z87.821Personal history of retained foreign body fully removedPersonal history of other diseases and conditions (Z87)
Z87.828Personal history of other (healed) physical injury and traumaPersonal history of other diseases and conditions (Z87)
Z87.891Personal history of nicotine dependencePersonal history of other diseases and conditions (Z87)
Z87.892Personal history of anaphylaxisPersonal history of other diseases and conditions (Z87)
Z87.898Personal history of other specified conditionsPersonal history of other diseases and conditions (Z87)
Z88.0Allergy status to penicillinAllergy status to drug/meds/biol subst (Z88)
Z88.1Allergy status to other antibiotic agents statusAllergy status to drug/meds/biol subst (Z88)
Z88.2Allergy status to sulfonamides statusAllergy status to drug/meds/biol subst (Z88)
Z88.3Allergy status to other anti-infective agents statusAllergy status to drug/meds/biol subst (Z88)
Z88.4Allergy status to anesthetic agent statusAllergy status to drug/meds/biol subst (Z88)
Z88.5Allergy status to narcotic agent statusAllergy status to drug/meds/biol subst (Z88)
Z88.6Allergy status to analgesic agent statusAllergy status to drug/meds/biol subst (Z88)
Z88.7Allergy status to serum and vaccine statusAllergy status to drug/meds/biol subst (Z88)
Z88.8Allergy status to other drugs, medicaments and biological substances statusAllergy status to drug/meds/biol subst (Z88)
Z88.9Allergy status to unspecified drugs, medicaments and biological substances statusAllergy status to drug/meds/biol subst (Z88)
Z89.011Acquired absence of right thumbAcquired absence of limb (Z89)
Z89.012Acquired absence of left thumbAcquired absence of limb (Z89)
Z89.019Acquired absence of unspecified thumbAcquired absence of limb (Z89)
Z89.021Acquired absence of right finger(s)Acquired absence of limb (Z89)
Z89.022Acquired absence of left finger(s)Acquired absence of limb (Z89)
Z89.029Acquired absence of unspecified finger(s)Acquired absence of limb (Z89)
Z89.111Acquired absence of right handAcquired absence of limb (Z89)
Z89.112Acquired absence of left handAcquired absence of limb (Z89)
Z89.119Acquired absence of unspecified handAcquired absence of limb (Z89)
Z89.121Acquired absence of right wristAcquired absence of limb (Z89)
Z89.122Acquired absence of left wristAcquired absence of limb (Z89)
Z89.129Acquired absence of unspecified wristAcquired absence of limb (Z89)
Z89.201Acquired absence of right upper limb, unspecified levelAcquired absence of limb (Z89)
Z89.202Acquired absence of left upper limb, unspecified levelAcquired absence of limb (Z89)
Z89.209Acquired absence of unspecified upper limb, unspecified levelAcquired absence of limb (Z89)
Z89.211Acquired absence of right upper limb below elbowAcquired absence of limb (Z89)
Z89.212Acquired absence of left upper limb below elbowAcquired absence of limb (Z89)
Z89.219Acquired absence of unspecified upper limb below elbowAcquired absence of limb (Z89)
Z89.221Acquired absence of right upper limb above elbowAcquired absence of limb (Z89)
Z89.222Acquired absence of left upper limb above elbowAcquired absence of limb (Z89)
Z89.229Acquired absence of unspecified upper limb above elbowAcquired absence of limb (Z89)
Z89.231Acquired absence of right shoulderAcquired absence of limb (Z89)
Z89.232Acquired absence of left shoulderAcquired absence of limb (Z89)
Z89.239Acquired absence of unspecified shoulderAcquired absence of limb (Z89)
Z89.411Acquired absence of right great toeAcquired absence of limb (Z89)
Z89.412Acquired absence of left great toeAcquired absence of limb (Z89)
Z89.419Acquired absence of unspecified great toeAcquired absence of limb (Z89)
Z89.421Acquired absence of other right toe(s)Acquired absence of limb (Z89)
Z89.422Acquired absence of other left toe(s)Acquired absence of limb (Z89)
Z89.429Acquired absence of other toe(s), unspecified sideAcquired absence of limb (Z89)
Z89.431Acquired absence of right footAcquired absence of limb (Z89)
Z89.432Acquired absence of left footAcquired absence of limb (Z89)
Z89.439Acquired absence of unspecified footAcquired absence of limb (Z89)
Z89.441Acquired absence of right ankleAcquired absence of limb (Z89)
Z89.442Acquired absence of left ankleAcquired absence of limb (Z89)
Z89.449Acquired absence of unspecified ankleAcquired absence of limb (Z89)
Z89.511Acquired absence of right leg below kneeAcquired absence of limb (Z89)
Z89.512Acquired absence of left leg below kneeAcquired absence of limb (Z89)
Z89.519Acquired absence of unspecified leg below kneeAcquired absence of limb (Z89)
Z89.521Acquired absence of right kneeAcquired absence of limb (Z89)
Z89.522Acquired absence of left kneeAcquired absence of limb (Z89)
Z89.529Acquired absence of unspecified kneeAcquired absence of limb (Z89)
Z89.611Acquired absence of right leg above kneeAcquired absence of limb (Z89)
Z89.612Acquired absence of left leg above kneeAcquired absence of limb (Z89)
Z89.619Acquired absence of unspecified leg above kneeAcquired absence of limb (Z89)
Z89.621Acquired absence of right hip jointAcquired absence of limb (Z89)
Z89.622Acquired absence of left hip jointAcquired absence of limb (Z89)
Z89.629Acquired absence of unspecified hip jointAcquired absence of limb (Z89)
Z89.9Acquired absence of limb, unspecifiedAcquired absence of limb (Z89)
Z90.01Acquired absence of eyeAcquired absence of organs, not elsewhere classified (Z90)
Z90.02Acquired absence of larynxAcquired absence of organs, not elsewhere classified (Z90)
Z90.09Acquired absence of other part of head and neckAcquired absence of organs, not elsewhere classified (Z90)
Z90.2Acquired absence of lung [part of]Acquired absence of organs, not elsewhere classified (Z90)
Z90.3Acquired absence of stomach [part of]Acquired absence of organs, not elsewhere classified (Z90)
Z90.410Acquired total absence of pancreasAcquired absence of organs, not elsewhere classified (Z90)
Z90.411Acquired partial absence of pancreasAcquired absence of organs, not elsewhere classified (Z90)
Z90.49Acquired absence of other specified parts of digestive tractAcquired absence of organs, not elsewhere classified (Z90)
Z90.5Acquired absence of kidneyAcquired absence of organs, not elsewhere classified (Z90)
Z90.6Acquired absence of other parts of urinary tractAcquired absence of organs, not elsewhere classified (Z90)
Z90.710Acquired absence of both cervix and uterusAcquired absence of organs, not elsewhere classified (Z90)
Z90.711Acquired absence of uterus with remaining cervical stumpAcquired absence of organs, not elsewhere classified (Z90)
Z90.712Acquired absence of cervix with remaining uterusAcquired absence of organs, not elsewhere classified (Z90)
Z90.721Acquired absence of ovaries, unilateralAcquired absence of organs, not elsewhere classified (Z90)
Z90.722Acquired absence of ovaries, bilateralAcquired absence of organs, not elsewhere classified (Z90)
Z90.79Acquired absence of other genital organ(s)Acquired absence of organs, not elsewhere classified (Z90)
Z90.81Acquired absence of spleenAcquired absence of organs, not elsewhere classified (Z90)
Z90.89Acquired absence of other organsAcquired absence of organs, not elsewhere classified (Z90)
Z91.010Allergy to peanutsPersonal risk factors, not elsewhere classified (Z91)
Z91.011Allergy to milk productsPersonal risk factors, not elsewhere classified (Z91)
Z91.012Allergy to eggsPersonal risk factors, not elsewhere classified (Z91)
Z91.013Allergy to seafoodPersonal risk factors, not elsewhere classified (Z91)
Z91.018Allergy to other foodsPersonal risk factors, not elsewhere classified (Z91)
Z91.02Food additives allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.030Bee allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.038Other insect allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.040Latex allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.041Radiographic dye allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.048Other nonmedicinal substance allergy statusPersonal risk factors, not elsewhere classified (Z91)
Z91.09Other allergy status, other than to drugs and biological substancesPersonal risk factors, not elsewhere classified (Z91)
Z91.11Patient's noncompliance with dietary regimenPersonal risk factors, not elsewhere classified (Z91)
Z91.120Patient's intentional underdosing of medication regimen due to financial hardshipPersonal risk factors, not elsewhere classified (Z91)
Z91.128Patient's intentional underdosing of medication regimen for other reasonPersonal risk factors, not elsewhere classified (Z91)
Z91.130Patient's unintentional underdosing of medication regimen due to age-related debilityPersonal risk factors, not elsewhere classified (Z91)
Z91.138Patient's unintentional underdosing of medication regimen for other reasonPersonal risk factors, not elsewhere classified (Z91)
Z91.14Patient's other noncompliance with medication regimenPersonal risk factors, not elsewhere classified (Z91)
Z91.15Patient's noncompliance with renal dialysisPersonal risk factors, not elsewhere classified (Z91)
Z91.19Patient's noncompliance with other medical treatment and regimenPersonal risk factors, not elsewhere classified (Z91)
Z91.410Personal history of adult physical and sexual abusePersonal risk factors, not elsewhere classified (Z91)
Z91.411Personal history of adult psychological abusePersonal risk factors, not elsewhere classified (Z91)
Z91.412Personal history of adult neglectPersonal risk factors, not elsewhere classified (Z91)
Z91.419Personal history of unspecified adult abusePersonal risk factors, not elsewhere classified (Z91)
Z91.49Other personal history of psychological trauma, not elsewhere classifiedPersonal risk factors, not elsewhere classified (Z91)
Z91.5Personal history of self-harmPersonal risk factors, not elsewhere classified (Z91)
Z91.81History of fallingPersonal risk factors, not elsewhere classified (Z91)
Z91.82Personal history of military deploymentPersonal risk factors, not elsewhere classified (Z91)
Z91.841Risk for dental caries, lowPersonal risk factors, not elsewhere classified (Z91)
Z91.842Risk for dental caries, moderatePersonal risk factors, not elsewhere classified (Z91)
Z91.843Risk for dental caries, highPersonal risk factors, not elsewhere classified (Z91)
Z91.849Unspecified risk for dental cariesPersonal risk factors, not elsewhere classified (Z91)
Z91.89Other specified personal risk factors, not elsewhere classifiedPersonal risk factors, not elsewhere classified (Z91)
Z92.0Personal history of contraceptionPersonal history of medical treatment (Z92)
Z92.21Personal history of antineoplastic chemotherapyPersonal history of medical treatment (Z92)
Z92.22Personal history of monoclonal drug therapyPersonal history of medical treatment (Z92)
Z92.23Personal history of estrogen therapyPersonal history of medical treatment (Z92)
Z92.240Personal history of inhaled steroid therapyPersonal history of medical treatment (Z92)
Z92.241Personal history of systemic steroid therapyPersonal history of medical treatment (Z92)
Z92.25Personal history of immunosupression therapyPersonal history of medical treatment (Z92)
Z92.29Personal history of other drug therapyPersonal history of medical treatment (Z92)
Z92.3Personal history of irradiationPersonal history of medical treatment (Z92)
Z92.81Personal history of extracorporeal membrane oxygenation (ECMO)Personal history of medical treatment (Z92)
Z92.82Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facilityPersonal history of medical treatment (Z92)
Z92.83Personal history of failed moderate sedationPersonal history of medical treatment (Z92)
Z92.84Personal history of unintended awareness under general anesthesiaPersonal history of medical treatment (Z92)
Z92.89Personal history of other medical treatmentPersonal history of medical treatment (Z92)
Z93.0Tracheostomy statusArtificial opening status (Z93)
Z93.1Gastrostomy statusArtificial opening status (Z93)
Z93.2Ileostomy statusArtificial opening status (Z93)
Z93.3Colostomy statusArtificial opening status (Z93)
Z93.4Other artificial openings of gastrointestinal tract statusArtificial opening status (Z93)
Z93.50Unspecified cystostomy statusArtificial opening status (Z93)
Z93.51Cutaneous-vesicostomy statusArtificial opening status (Z93)
Z93.52Appendico-vesicostomy statusArtificial opening status (Z93)
Z93.59Other cystostomy statusArtificial opening status (Z93)
Z93.6Other artificial openings of urinary tract statusArtificial opening status (Z93)
Z93.8Other artificial opening statusArtificial opening status (Z93)
Z93.9Artificial opening status, unspecifiedArtificial opening status (Z93)
Z94.0Kidney transplant statusTransplanted organ and tissue status (Z94)
Z94.1Heart transplant statusTransplanted organ and tissue status (Z94)
Z94.2Lung transplant statusTransplanted organ and tissue status (Z94)
Z94.3Heart and lungs transplant statusTransplanted organ and tissue status (Z94)
Z94.4Liver transplant statusTransplanted organ and tissue status (Z94)
Z94.5Skin transplant statusTransplanted organ and tissue status (Z94)
Z94.6Bone transplant statusTransplanted organ and tissue status (Z94)
Z94.7Corneal transplant statusTransplanted organ and tissue status (Z94)
Z94.81Bone marrow transplant statusTransplanted organ and tissue status (Z94)
Z94.82Intestine transplant statusTransplanted organ and tissue status (Z94)
Z94.83Pancreas transplant statusTransplanted organ and tissue status (Z94)
Z94.84Stem cells transplant statusTransplanted organ and tissue status (Z94)
Z94.89Other transplanted organ and tissue statusTransplanted organ and tissue status (Z94)
Z94.9Transplanted organ and tissue status, unspecifiedTransplanted organ and tissue status (Z94)
Z95.0Presence of cardiac pacemakerPresence of cardiac and vascular implants and grafts (Z95)
Z95.1Presence of aortocoronary bypass graftPresence of cardiac and vascular implants and grafts (Z95)
Z95.2Presence of prosthetic heart valvePresence of cardiac and vascular implants and grafts (Z95)
Z95.3Presence of xenogenic heart valvePresence of cardiac and vascular implants and grafts (Z95)
Z95.4Presence of other heart-valve replacementPresence of cardiac and vascular implants and grafts (Z95)
Z95.5Presence of coronary angioplasty implant and graftPresence of cardiac and vascular implants and grafts (Z95)
Z95.810Presence of automatic (implantable) cardiac defibrillatorPresence of cardiac and vascular implants and grafts (Z95)
Z95.811Presence of heart assist devicePresence of cardiac and vascular implants and grafts (Z95)
Z95.812Presence of fully implantable artificial heartPresence of cardiac and vascular implants and grafts (Z95)
Z95.818Presence of other cardiac implants and graftsPresence of cardiac and vascular implants and grafts (Z95)
Z95.820Peripheral vascular angioplasty status with implants and graftsPresence of cardiac and vascular implants and grafts (Z95)
Z95.828Presence of other vascular implants and graftsPresence of cardiac and vascular implants and grafts (Z95)
Z95.9Presence of cardiac and vascular implant and graft, unspecifiedPresence of cardiac and vascular implants and grafts (Z95)
Z96.0Presence of urogenital implantsPresence of other functional implants (Z96)
Z96.1Presence of intraocular lensPresence of other functional implants (Z96)
Z96.20Presence of otological and audiological implant, unspecifiedPresence of other functional implants (Z96)
Z96.21Cochlear implant statusPresence of other functional implants (Z96)
Z96.22Myringotomy tube(s) statusPresence of other functional implants (Z96)
Z96.29Presence of other otological and audiological implantsPresence of other functional implants (Z96)
Z96.3Presence of artificial larynxPresence of other functional implants (Z96)
Z96.41Presence of insulin pump (external) (internal)Presence of other functional implants (Z96)
Z96.49Presence of other endocrine implantsPresence of other functional implants (Z96)
Z96.5Presence of tooth-root and mandibular implantsPresence of other functional implants (Z96)
Z96.60Presence of unspecified orthopedic joint implantPresence of other functional implants (Z96)
Z96.611Presence of right artificial shoulder jointPresence of other functional implants (Z96)
Z96.612Presence of left artificial shoulder jointPresence of other functional implants (Z96)
Z96.619Presence of unspecified artificial shoulder jointPresence of other functional implants (Z96)
Z96.621Presence of right artificial elbow jointPresence of other functional implants (Z96)
Z96.622Presence of left artificial elbow jointPresence of other functional implants (Z96)
Z96.629Presence of unspecified artificial elbow jointPresence of other functional implants (Z96)
Z96.631Presence of right artificial wrist jointPresence of other functional implants (Z96)
Z96.632Presence of left artificial wrist jointPresence of other functional implants (Z96)
Z96.639Presence of unspecified artificial wrist jointPresence of other functional implants (Z96)
Z96.641Presence of right artificial hip jointPresence of other functional implants (Z96)
Z96.642Presence of left artificial hip jointPresence of other functional implants (Z96)
Z96.643Presence of artificial hip joint, bilateralPresence of other functional implants (Z96)
Z96.649Presence of unspecified artificial hip jointPresence of other functional implants (Z96)
Z96.651Presence of right artificial knee jointPresence of other functional implants (Z96)
Z96.652Presence of left artificial knee jointPresence of other functional implants (Z96)
Z96.653Presence of artificial knee joint, bilateralPresence of other functional implants (Z96)
Z96.659Presence of unspecified artificial knee jointPresence of other functional implants (Z96)
Z96.661Presence of right artificial ankle jointPresence of other functional implants (Z96)
Z96.662Presence of left artificial ankle jointPresence of other functional implants (Z96)
Z96.669Presence of unspecified artificial ankle jointPresence of other functional implants (Z96)
Z96.691Finger-joint replacement of right handPresence of other functional implants (Z96)
Z96.692Finger-joint replacement of left handPresence of other functional implants (Z96)
Z96.693Finger-joint replacement, bilateralPresence of other functional implants (Z96)
Z96.698Presence of other orthopedic joint implantsPresence of other functional implants (Z96)
Z96.7Presence of other bone and tendon implantsPresence of other functional implants (Z96)
Z96.81Presence of artificial skinPresence of other functional implants (Z96)
Z96.89Presence of other specified functional implantsPresence of other functional implants (Z96)
Z96.9Presence of functional implant, unspecifiedPresence of other functional implants (Z96)
Z97.0Presence of artificial eyePresence of other devices (Z97)
Z97.10Presence of artificial limb (complete) (partial), unspecifiedPresence of other devices (Z97)
Z97.11Presence of artificial right arm (complete) (partial)Presence of other devices (Z97)
Z97.12Presence of artificial left arm (complete) (partial)Presence of other devices (Z97)
Z97.13Presence of artificial right leg (complete) (partial)Presence of other devices (Z97)
Z97.14Presence of artificial left leg (complete) (partial)Presence of other devices (Z97)
Z97.15Presence of artificial arms, bilateral (complete) (partial)Presence of other devices (Z97)
Z97.16Presence of artificial legs, bilateral (complete) (partial)Presence of other devices (Z97)
Z97.2Presence of dental prosthetic device (complete) (partial)Presence of other devices (Z97)
Z97.3Presence of spectacles and contact lensesPresence of other devices (Z97)
Z97.4Presence of external hearing-aidPresence of other devices (Z97)
Z97.5Presence of (intrauterine) contraceptive devicePresence of other devices (Z97)
Z97.8Presence of other specified devicesPresence of other devices (Z97)
Z98.0Intestinal bypass and anastomosis statusOther postprocedural states (Z98)
Z98.1Arthrodesis statusOther postprocedural states (Z98)
Z98.2Presence of cerebrospinal fluid drainage deviceOther postprocedural states (Z98)
Z98.3Post therapeutic collapse of lung statusOther postprocedural states (Z98)
Z98.41Cataract extraction status, right eyeOther postprocedural states (Z98)
Z98.42Cataract extraction status, left eyeOther postprocedural states (Z98)
Z98.49Cataract extraction status, unspecified eyeOther postprocedural states (Z98)
Z98.51Tubal ligation statusOther postprocedural states (Z98)
Z98.52Vasectomy statusOther postprocedural states (Z98)
Z98.61Coronary angioplasty statusOther postprocedural states (Z98)
Z98.62Peripheral vascular angioplasty statusOther postprocedural states (Z98)
Z98.810Dental sealant statusOther postprocedural states (Z98)
Z98.811Dental restoration statusOther postprocedural states (Z98)
Z98.818Other dental procedure statusOther postprocedural states (Z98)
Z98.82Breast implant statusOther postprocedural states (Z98)
Z98.83Filtering (vitreous) bleb after glaucoma surgery statusOther postprocedural states (Z98)
Z98.84Bariatric surgery statusOther postprocedural states (Z98)
Z98.85Transplanted organ removal statusOther postprocedural states (Z98)
Z98.86Personal history of breast implant removalOther postprocedural states (Z98)
Z98.870Personal history of in utero procedure during pregnancyOther postprocedural states (Z98)
Z98.871Personal history of in utero procedure while a fetusOther postprocedural states (Z98)
Z98.890Other specified postprocedural statesOther postprocedural states (Z98)
Z98.891History of uterine scar from previous surgeryOther postprocedural states (Z98)
Z99.0Dependence on aspiratorDependence on enabling machines and devices, NEC (Z99)
Z99.2Dependence on renal dialysisDependence on enabling machines and devices, NEC (Z99)
Z99.3Dependence on wheelchairDependence on enabling machines and devices, NEC (Z99)
Z99.81Dependence on supplemental oxygenDependence on enabling machines and devices, NEC (Z99)
Z99.89Dependence on other enabling machines and devicesDependence on enabling machines and devices, NEC (Z99)